{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:36:25Z","timestamp":1790818585583,"version":"4.1.0"},"reference-count":594,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100006162","name":"Foundation for Support of Science and Technology of the State of Pernambuco","doi-asserted-by":"publisher","award":["IBPG-1241-4.03\/16"],"award-info":[{"award-number":["IBPG-1241-4.03\/16"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Antibiotic resistance can be characterized, in biochemical terms, as an antibiotic\u2019s inability to reach\nits bacterial target at a concentration that was previously effective. Microbial resistance to different agents can\nbe intrinsic or acquired. Intrinsic resistance occurs due to inherent functional or structural characteristics of the\nbacteria, such as antibiotic-inactivating enzymes, nonspecific efflux pumps, and permeability barriers. On the\nother hand, bacteria can acquire resistance mechanisms via horizontal gene transfer in mobile genetic elements\nsuch as plasmids. Acquired resistance mechanisms include another category of efflux pumps with more specific\nsubstrates, which are plasmid-encoded. Efflux pumps are considered one of the main mechanisms of bacterial\nresistance to antibiotics and biocides, presenting themselves as integral membrane transporters. They are essential\nin both bacterial physiology and defense and are responsible for exporting structurally diverse substrates,\nfalling into the following main families: ATP-binding cassette (ABC), multidrug and toxic compound extrusion\n(MATE), major facilitator superfamily (MFS), small multidrug resistance (SMR) and resistance-nodulation-cell\ndivision (RND). The Efflux pumps NorA and Tet(K) of the MFS family, MepA of the MATE family, and\nMsrA of the ABC family are some examples of specific efflux pumps that act in the extrusion of antibiotics. In\nthis review, we address bacterial efflux pump inhibitors (EPIs), including 1,8-naphthyridine sulfonamide derivatives,\ngiven the pre-existing knowledge about the chemical characteristics that favor their biological activity.\nThe modification and emergence of resistance to new EPIs justify further research on this theme, aiming to develop\nefficient compounds for clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1381612829666221212101501","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T04:31:47Z","timestamp":1670992307000},"page":"323-355","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["NorA, Tet(K), MepA, and MsrA Efflux Pumps in Staphylococcus aureus, their Inhibitors\nand 1,8-Naphthyridine Sulfonamides"],"prefix":"10.2174","volume":"29","author":[{"given":"Henrique Douglas","family":"Melo Coutinho","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edcera Datiane","family":"de Morais Oliveira-Tintino","sequence":"additional","affiliation":[{"name":"Department of Antibiotics, Laboratory of Pharmatoxicological Prospecting of Bioactive Products, Federal University of Pernambuco,\nUFPE, Recife, PE, Brazil"},{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Feitosa","family":"Muniz","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Rodrigues","family":"dos Santos Barbosa","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo Luiz","family":"Silva Pereira","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00eada Maria","family":"Begnini","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Regional University of Blumenau, FURB,\nItoupava Seca, 89030-903, Blumenau, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Andrade","family":"Rebelo","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Regional University of Blumenau, FURB,\nItoupava Seca, 89030-903, Blumenau, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Everson","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Paran\u00e1, Curitiba, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro Lucio","family":"Mireski","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Regional University of Blumenau, FURB,\nItoupava Seca, 89030-903, Blumenau, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Caroline","family":"Nasato","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Regional University of Blumenau, FURB,\nItoupava Seca, 89030-903, Blumenau, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Lacowicz Krautler","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Regional University of Blumenau, FURB,\nItoupava Seca, 89030-903, Blumenau, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Vinicius","family":"Barros Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Laboratory of Biology and Toxicology, Regional University of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Silvino","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Antibiotics, Laboratory of Pharmatoxicological Prospecting of Bioactive Products, Federal University of Pernambuco,\nUFPE, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Magno","family":"Rodrigues Teixeira","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Simulations and Molecular Spectroscopy, Regional University of Cariri,\nURCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saulo Relison","family":"Tintino","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Microbiology and Molecular Biology, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin Rose Alencar","family":"de Menezes","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Laboratory of Pharmacology and Molecular Chemistry, Regional\nUniversity of Cariri, URCA, Crato, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha Gon\u00e7alves","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Antibiotics, Laboratory of Pharmatoxicological Prospecting of Bioactive Products, Federal University of Pernambuco,\nUFPE, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/cc7127","volume":"12","author":"Cross AS","year":"2008","unstructured":"Cross AS; What Is a Virulence Factor? Crit Care 2008,12(6),196","journal-title":"Crit Care"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/CMR.15.4.647-679.2002","volume":"15","author":"Mart&#xED;nez J.L.","year":"2002","unstructured":"Mart&#xED;nez J.L.; Baquero F.; Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002,15(4),647-679","journal-title":"Clin Microbiol Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/molbev\/msaa173","volume":"37","author":"Andras J.P.","year":"2020","unstructured":"Andras J.P.; Fields P.D.; Du Pasquier L.; Fredericksen M.; Ebert D.; Genome-wide association analysis identifies a genetic basis of infectivity in a model bacterial pathogen. Mol Biol Evol 2020,37(12),3439-3452","journal-title":"Mol Biol Evol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature02759","volume":"430","author":"Morens D.M.","year":"2004","unstructured":"Morens D.M.; Folkers G.K.; Fauci A.S.; The challenge of emerging and re-emerging infectious diseases. Nature 2004,430(6996),242-249","journal-title":"Nature"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/pmj.78.918.216","volume":"78","author":"Wilson J.W.","year":"2002","unstructured":"Wilson J.W.; Schurr M.J.; LeBlanc C.L.; Ramamurthy R.; Buchanan K.L.; Nickerson C.A.; Mechanisms of bacterial pathogenicity. Postgrad Med J 2002,78(918),216-224","journal-title":"Postgrad Med J"},{"key":"ref=6","author":"Mascaretti O.A.","year":"2014","unstructured":"Mascaretti O.A.; Bacterial Pathogenesis.  Bacteria versus Antibacterial Agents American Society for Microbiology (ASM) 2014","journal-title":"Bacteria versus Antibacterial Agents American Society for Microbiology (ASM)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","volume":"15","author":"Fisher R.A.","year":"2017","unstructured":"Fisher R.A.; Gollan B.; Helaine S.; Persistent bacterial infections and persister cells. Nat Rev Microbiol 2017,15(8),453-464","journal-title":"Nat Rev Microbiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/jeb.12864","volume":"29","author":"Vogwill T.","year":"2016","unstructured":"Vogwill T.; Comfort A.C.; Furi&#xF3; V.; MacLean R.C.; Persistence and resistance as complementary bacterial adaptations to antibiotics. J Evol Biol 2016,29(6),1223-1233","journal-title":"J Evol Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.fm.2016.10.029","volume":"62","author":"Ge B.","year":"2017","unstructured":"Ge B.; Mukherjee S.; Hsu C.H.; MRSA and multidrug-resistant Staphylococcus aureus in U.S. retail meats, 2010-2011. Food Microbiol 2017,62,289-297","journal-title":"Food Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e17936","DOI":"10.1371\/journal.pone.0017936","volume":"6","author":"Monecke S.","year":"2011","unstructured":"Monecke S.; Coombs G.; Shore A.C.; A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 2011,6(4),e17936","journal-title":"PLoS One"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/156652409787581637","volume":"9","author":"Deurenberg R.","year":"2009","unstructured":"Deurenberg R.; Stobberingh E.; The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus au-reus. Curr Mol Med 2009,9(2),100-115","journal-title":"Curr Mol Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.2147\/IJN.S169935","volume":"13","author":"Zhou K.","year":"2018","unstructured":"Zhou K.; Li C.; Chen D.; A review on nanosystems as an effective approach against infections of Staphylococcus aureus. Int J Nanomedicine 2018,13,7333-7347","journal-title":"Int J Nanomedicine"},{"key":"ref=13","first-page":"32","volume":"21","author":"Lima M.F.P.","year":"2015","unstructured":"Lima M.F.P.; Borges M.A.; Parente R.S.; J&#xFA;nior R.C.V.; De Oliveira M.E.; Staphylococcus aureus and hospital infections. Revis&#xE3;o De Literatura 2015,21(1),32-39","journal-title":"Revis&#xE3;o De Literatura"},{"key":"ref=14","unstructured":"Publishes list of bacteria for which new antibiotics are urgently needed. WHOAvaialble from:"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1126\/science.aar3777","volume":"360","author":"Baker S.","year":"2018","unstructured":"Baker S.; Thomson N.; Weill F.X.; Holt K.E.; Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens. Science 2018,360(6390),733-738","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0300985813511131","volume":"51","author":"Gyles C.","year":"2014","unstructured":"Gyles C.; Boerlin P.; Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease. Vet Pathol 2014,51(2),328-340","journal-title":"Vet Pathol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41559-018-0547-x","volume":"2","author":"Gifford D.R.","year":"2018","unstructured":"Gifford D.R.; Furi&#xF3; V.; Papkou A.; Vogwill T.; Oliver A.; MacLean R.C.; Identifying and exploiting genes that potentiate the evolution of antibiotic resistance. Nat Ecol Evol 2018,2(6),1033-1039","journal-title":"Nat Ecol Evol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11514","volume":"489","author":"Blount Z.D.","year":"2012","unstructured":"Blount Z.D.; Barrick J.E.; Davidson C.J.; Lenski R.E.; Genomic analysis of a key innovation in an experimental Escherichia coli population. Nature 2012,489(7417),513-518","journal-title":"Nature"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1568026618666180206095224","volume":"18","author":"Pontes D.S.","year":"2018","unstructured":"Pontes D.S.; de Araujo R.S.A.; Dantas N.; Genetic mechanisms of antibiotic resistance and the role of antibiotic adjuvants. Curr Top Med Chem 2018,18(1),42-74","journal-title":"Curr Top Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fmicb.2011.00203","volume":"2","author":"van Hoek A.H.A.M.","year":"2011","unstructured":"van Hoek A.H.A.M.; Mevius D.; Guerra B.; Mullany P.; Roberts A.P.; Aarts H.J.M.; Acquired antibiotic resistance genes: An overview. Front Microbiol 2011,2,203","journal-title":"Front Microbiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","volume":"12","author":"Miller W.R.","year":"2014","unstructured":"Miller W.R.; Munita J.M.; Arias C.A.; Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 2014,12(10),1221-1236","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1128\/AAC.39.12.2650","volume":"39","author":"Kaatz G.W.","year":"1995","unstructured":"Kaatz G.W.; Seo S.M.; Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1995,39(12),2650-2655","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijantimicag.2012.10.010","volume":"41","author":"Lavigne J.P.","year":"2013","unstructured":"Lavigne J.P.; Sotto A.; Nicolas-Chanoine M.H.; Bouziges N.; Pag&#xE8;s J.M.; Davin-Regli A.; An adaptive response of Enterobacter aerogenes to imipenem: Regulation of porin balance in clinical isolates. Int J Antimicrob Agents 2013,41(2),130-136","journal-title":"Int J Antimicrob Agents"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1128\/AAC.33.9.1535","volume":"33","author":"Ubukata K.","year":"1989","unstructured":"Ubukata K.; Itoh-Yamashita N.; Konno M.; Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1989,33(9),1535-1539","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/plas.1993.1045","volume":"30","author":"Guay G.G.","year":"1993","unstructured":"Guay G.G.; Khan S.A.; Rothstein D.M.; The tet(K) gene of plasmid pT181 of Staphylococcus aureus encodes an efflux protein that contains 14 transmembrane helices. Plasmid 1993,30(2),163-166","journal-title":"Plasmid"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.49.5.1857-1864.2005","volume":"49","author":"Kaatz G.W.","year":"2005","unstructured":"Kaatz G.W.; McAleese F.; Seo S.M.; Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 2005,49(5),1857-1864","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0378-1119(94)00833-E","volume":"153","author":"Ross J.I.","year":"1995","unstructured":"Ross J.I.; Eady E.A.; Cove J.H.; Baumberg S.; Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 1995,153(1),93-98","journal-title":"Gene"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jac\/dki171","volume":"56","author":"Poole K.","year":"2005","unstructured":"Poole K.; Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005,56(1),20-51","journal-title":"J Antimicrob Chemother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"Blair J.M.A.","year":"2015","unstructured":"Blair J.M.A.; Webber M.A.; Baylay A.J.; Ogbolu D.O.; Piddock L.J.V.; Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015,13(1),42-51","journal-title":"Nat Rev Microbiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","volume":"128","author":"Alekshun M.N.","year":"2007","unstructured":"Alekshun M.N.; Levy S.B.; Molecular mechanisms of antibacterial multidrug resistance. Cell 2007,128(6),1037-1050","journal-title":"Cell"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874285801307010059","volume":"7","author":"Costa S.S.","year":"2013","unstructured":"Costa S.S.; Viveiros M.; Amaral L.; Couto I.; Multidrug efflux pumps in Staphylococcus aureus: An update. Open Microbiol J 2013,7(1),59-71","journal-title":"Open Microbiol J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ddstr.2006.05.005","volume":"3","author":"Poole K.","year":"2006","unstructured":"Poole K.; Lomovskaya O.; Can efflux inhibitors really counter resistance? Drug Discov Today Ther Strateg 2006,3(2),145-152","journal-title":"Drug Discov Today Ther Strateg"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1389557517666170510105506","volume":"18","author":"Kapp E","year":"2018","unstructured":"Kapp E; Malan SF; Joubert J; Sampson SL; Small molecule efflux pump inhibitors in Mycobacterium tuberculosis: A rational drug design perspective. Mini Rev Med Chem 2018,18(1),72-86","journal-title":"Mini Rev Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkl493","volume":"59","author":"Mahamoud A.","year":"2007","unstructured":"Mahamoud A.; Chevalier J.; Alibert-Franco S.; Kern W.V.; Pag&#xE8;s J.M.; Antibiotic efflux pumps in gram-negative bacteria: The inhibitor response strategy. J Antimicrob Chemother 2007,59(6),1223-1229","journal-title":"J Antimicrob Chemother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1016\/S1074-5521(00)00126-5","volume":"7","author":"Wright G.D.","year":"2000","unstructured":"Wright G.D.; Resisting resistance: New chemical strategies for battling superbugs. Chem Biol 2000,7(6),R127-R132","journal-title":"Chem Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.2174\/1568026620666200704135837","volume":"20","author":"Monteiro K.L.C.","year":"2020","unstructured":"Monteiro K.L.C.; de Aquino T.M.; Mendon&#xE7;a Junior F.J.B.; An update on Staphylococcus aureus NorA efflux pump inhibitors. Curr Top Med Chem 2020,20(24),2168-2185","journal-title":"Curr Top Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","volume":"71","author":"Lomovskaya O.","year":"2006","unstructured":"Lomovskaya O.; Bostian K.A.; Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use. Biochem Pharmacol 2006,71(7),910-918","journal-title":"Biochem Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tim.2017.11.005","volume":"26","author":"Bell G.","year":"2018","unstructured":"Bell G.; MacLean C.; The search for \u2018Evolution-Proof\u2019 antibiotics. Trends Microbiol 2018,26(6),471-483","journal-title":"Trends Microbiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrmicro.2017.75","volume":"15","author":"Sommer M.O.A.","year":"2017","unstructured":"Sommer M.O.A.; Munck C.; Toft-Kehler R.V.; Andersson D.I.; Prediction of antibiotic resistance: Time for a new preclinical paradigm? Nat Rev Microbiol 2017,15(11),689-696","journal-title":"Nat Rev Microbiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"Baym M.","year":"2016","unstructured":"Baym M.; Stone L.K.; Kishony R.; Multidrug evolutionary strategies to reverse antibiotic resistance. Science 2016,351(6268),aad3292","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2016.09.025","volume":"133","author":"Fernandes P.","year":"2017","unstructured":"Fernandes P.; Martens E.; Antibiotics in late clinical development. Biochem Pharmacol 2017,133,152-163","journal-title":"Biochem Pharmacol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1070\/RC2001v070n04ABEH000617","volume":"70","author":"Litvinov V.P.","year":"2001","unstructured":"Litvinov V.P.; Roman S. V.; Dyachenko V.D.; Pyridopyridines. Russ Chem Rev 2001,70,299-320","journal-title":"Russ Chem Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0065-2725(06)91004-6","volume":"91","author":"Litvinov V.P.","year":"2006","unstructured":"Litvinov V.P.; Advances in the chemistry of naphthyridines. Adv Heterocycl Chem 2006,91,189-300","journal-title":"Adv Heterocycl Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00471187","volume":"15","author":"Czuba W.","year":"1979","unstructured":"Czuba W.; Synthesis and reactions of naphthyridines (review). Chem Heterocycl Compd 1979,15(1),1-13","journal-title":"Chem Heterocycl Compd"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/187152007784111313","volume":"7","author":"Srivastava S.","year":"2007","unstructured":"Srivastava S.; Jha A.; Agarwal S.; Mukherjee R.; Burman A.; Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anticancer Agents Med Chem 2007,7(6),685-709","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF00766678","volume":"19","author":"Noravyan A.S.","year":"1985","unstructured":"Noravyan A.S.; Paronikyan E.G.; Vartanyan S.A.; Synthesis and pharmacological properties of naphthyridines (review). Pharm Chem J 1985,19(7),439-448","journal-title":"Pharm Chem J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/jm01240a021","volume":"5","author":"Lesher G.Y.","year":"1962","unstructured":"Lesher G.Y.; Froelich E.J.; Gruett M.D.; Bailey J.H.; Brundage R.P.; 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem 1962,5(5),1063-1065","journal-title":"J Med Pharm Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1464-410X.1964.tb09478.x","volume":"36","author":"Thompson R.E.M.","year":"1964","unstructured":"Thompson R.E.M.; Rae J.; NEGRAM (1-ethyI-7-methyl-1, 8-naphthyridine-4-one-3-carboxylic acid): A new antibacterial agent for the treatment of urinary infection report of a trial in general practice. Br J Urol 1964,36(1),42-47","journal-title":"Br J Urol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ardp.201500237","volume":"348","author":"Madaan A.","year":"2015","unstructured":"Madaan A.; Verma R.; Kumar V.; Singh A.T.; Jain S.K.; Jaggi M.; 1,8-Naphthyridine derivatives: A review of multiple biological activities. Arch Pharm 2015,348(12),837-860","journal-title":"Arch Pharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1021\/acsmedchemlett.5b00159","volume":"6","author":"Wang H.","year":"2015","unstructured":"Wang H.; Wang S.; Cheng L.; Discovery of Imidazo[1,2-&#x3B1;][1,8]naphthyridine derivatives as potential HCV entry inhibitor. ACS Med Chem Lett 2015,6(9),977-981","journal-title":"ACS Med Chem Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1039\/C3OB42525H","volume":"12","author":"Huang S.","year":"2014","unstructured":"Huang S.; Qing J.; Wang S.; Wang H.; Zhang L.; Tang Y.; Design and synthesis of imidazo[1,2-&#x3B1;][1,8]naphthyridine derivatives as anti-HCV agents via direct C\u2013H arylation. Org Biomol Chem 2014,12(15),2344-2348","journal-title":"Org Biomol Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/126323","volume":"2014","author":"Ahmed N.S.","year":"2014","unstructured":"Ahmed N.S.; AlFooty K.O.; Khalifah S.S.; Synthesis of 1,8-Naphthyridine derivatives under ultrasound irradiation and cytotoxic activity against HepG2 cell lines. J Chem 2014,2014,1-8","journal-title":"J Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ejmech.2007.10.010","volume":"43","author":"Roma G.","year":"2008","unstructured":"Roma G.; Grossi G.; Di Braccio M.; 1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and\/or analgesic activities, but no acute gastrolesivity. Eur J Med Chem 2008,43(8),1665-1680","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/jm00084a019","volume":"35","author":"Kuroda T.","year":"1992","unstructured":"Kuroda T.; Suzuki F.; Tamura T.; Ohmori K.; Hosoe H.; A novel synthesis and potent antiinflammatory activity of 4-hydroxy-2(1H)-oxo-1-phenyl-1,8-naphthyridine-3-carboxamides. J Med Chem 1992,35(6),1130-1136","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejmech.2014.08.069","volume":"86","author":"Di Braccio M.","year":"2014","unstructured":"Di Braccio M.; Grossi G.; Alfei S.; 1,8-Naphthyridines IX. Potent anti-inflammatory and\/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivative. Eur J Med Chem 2014,86,394-405","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.intimp.2013.01.011","volume":"15","author":"Madaan A.","year":"2013","unstructured":"Madaan A.; Kumar V.; Verma R.; Singh A.T.; Jain S.K.; Jaggi M.; Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential. Int Immunopharmacol 2013,15(3),606-613","journal-title":"Int Immunopharmacol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/jm100051g","volume":"53","author":"Blum C.A.","year":"2010","unstructured":"Blum C.A.; Caldwell T.; Zheng X.; Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. J Med Chem 2010,53(8),3330-3348","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/157018007779422550","volume":"4","author":"Everson da Silva L.","year":"2007","unstructured":"Everson da Silva L.; Carlos Joussef A.; Kramer Pacheco L.; Synthesis and antiparasitic activity against trypanosoma cruzi and leishmania amazonensis of chlorinated 1,7- and 1,8-Naphthyridines. Lett Drug Des Discov 2007,4(2),154-159","journal-title":"Lett Drug Des Discov"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1002\/ange.19350484202","author":"Domagk G.","year":"1935","unstructured":"Domagk G.; Chemotherapy in bacterial infections. Angew Chemie 1935","journal-title":"Angew Chemie"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/bies.10114","volume":"24","author":"Bermingham A.","year":"2002","unstructured":"Bermingham A.; Derrick J.P.; The folic acid biosynthesis pathway in bacteria: Evaluation of potential for antibacterial drug discovery. BioEssays 2002,24(7),637-648","journal-title":"BioEssays"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3109\/14756366.2015.1016514","volume":"31","author":"Nasr T.","year":"2016","unstructured":"Nasr T.; Bondock S.; Eid S.; Design, synthesis, antimicrobial evaluation and molecular docking studies of some new 2,3-dihydrothiazoles and 4-thiazolidinones containing sulfisoxazole. J Enzyme Inhib Med Chem 2016,31(2),236-246","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=62","author":"Holmes N.E.","year":"2017","unstructured":"Holmes N.E.; Lindsay Grayson M.;  Sulfonamides Kucers the use of antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs 2017","journal-title":"Sulfonamides Kucers the use of antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs"},{"key":"ref=63","author":"Holt J.","year":"1994","unstructured":"Holt J.; Krieg N.; Sneath P.; Staley J.;  Williams S Bergey\u2019s Manual of Determinative Microbiology 1994","journal-title":"Williams S Bergey\u2019s Manual of Determinative Microbiology"},{"key":"ref=64","author":"Karl-Heinz Schleifer J.A.B.","year":"2009","unstructured":"Karl-Heinz Schleifer J.A.B.;  Family VIII Staphylococcaceae Fam Nov Bergey\u2019s manual of systematic bacteriology 2009","journal-title":"Family VIII Staphylococcaceae Fam Nov Bergey\u2019s manual of systematic bacteriology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1542\/pir.2017-0224","volume":"39","author":"Ondusko D.S.","year":"2018","unstructured":"Ondusko D.S.; Nolt D.; Staphylococcus aureus. Pediatr Rev 2018,39(6),287-298","journal-title":"Pediatr Rev"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tim.2019.01.008","volume":"27","author":"Parlet C.P.","year":"2019","unstructured":"Parlet C.P.; Brown M.M.; Horswill A.R.; Commensal staphylococci influence Staphylococcus aureus skin colonization and disease. Trends Microbiol 2019,27(6),497-507","journal-title":"Trends Microbiol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1128\/am.30.3.381-395.1975","volume":"30","author":"Kloos W.E.","year":"1975","unstructured":"Kloos W.E.; Musselwhite M.S.; Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 1975,30(3),381-395","journal-title":"Appl Microbiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1590\/S1676-24442007000600005","volume":"43","author":"Santos A.L.","year":"2007","unstructured":"Santos A.L.; Santos D.O.; Freitas C.C.; Staphylococcus aureus: Visiting a strain of hospital importance. J Bras Patol Med Lab 2007,43(6),413-423","journal-title":"J Bras Patol Med Lab"},{"key":"ref=69","author":"Kloos W.E.","year":"1991","unstructured":"Kloos W.E.; Lambe D.; Staphylococcus. Manual of Clinical Microbiology 1991","journal-title":"Manual of Clinical Microbiology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1590\/S1413-86702005000100012","volume":"9","author":"Cassettari V.C.","year":"2005","unstructured":"Cassettari V.C.; Strabelli T.; Medeiros E.A.S.; Staphylococcus aureus bacteremia: What is the impact of oxacillin resistance on mortality? Braz J Infect Dis 2005,9(1),70-76","journal-title":"Braz J Infect Dis"},{"key":"ref=71","author":"Trabulsi L.R.","year":"2005","unstructured":"Trabulsi L.R.; Alterthum F.;  Microbiology 2005","journal-title":"Microbiology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","volume":"357","author":"Kuroda M.","year":"2001","unstructured":"Kuroda M.; Ohta T.; Uchiyama I.; Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001,357(9264),1225-1240","journal-title":"Lancet"},{"key":"ref=73","author":"Howard J.B.","year":"1987","unstructured":"Howard J.B.; Kloos W.E.; Staphylococci. Clinical and Pathogenic Microbiology Missouri 1987","journal-title":"Clinical and Pathogenic Microbiology Missouri"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/S1413-86702003000300008","volume":"7","author":"Lutz L.","year":"2003","unstructured":"Lutz L.; Machado A.; Kuplich N.; Barth A.L.; Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil. Braz J Infect Dis 2003,7(3),224-228","journal-title":"Braz J Infect Dis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1590\/S1676-24442001000400004","volume":"37","author":"Oliveira G.A.","year":"2001","unstructured":"Oliveira G.A.; Okada S.S.; Guenta R.S.; Mamizuka E.M.; Assessment of vancomycin tolerance in 395 nosocomial oxacillin-resistant Staphylococcus aureus strains. J Bras Patol Med Lab 2001,37(4),239-246","journal-title":"J Bras Patol Med Lab"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/br.37.2.215-257.1973","volume":"37","author":"Knox K.W.","year":"1973","unstructured":"Knox K.W.; Wicken A.J.; Immunological properties of teichoic acids. Bacteriol Rev 1973,37(2),215-257","journal-title":"Bacteriol Rev"},{"key":"ref=77","author":"Waldvogel F.A.","year":"1990","unstructured":"Waldvogel F.A.; Staphylococcus aureus (Including Toxic Shock Syndrome). Principles and Practice of Infectious Diseases 1990","journal-title":"Principles and Practice of Infectious Diseases"},{"key":"ref=78","author":"Koneman E.W.","year":"2008","unstructured":"Koneman E.W.;  Microbiological Diagnosis: Text and Color Atlas 2008","journal-title":"Microbiological Diagnosis: Text and Color Atlas"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"Lowy F.D.","year":"1998","unstructured":"Lowy F.D.; Staphylococcus aureus Infections. N Engl J Med 1998,339(8),520-532","journal-title":"N Engl J Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","volume":"29","author":"Kahl B.C.","year":"2016","unstructured":"Kahl B.C.; Becker K.; L&#xF6;ffler B.; Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections. Clin Microbiol Rev 2016,29(2),401-427","journal-title":"Clin Microbiol Rev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/S0021-75572005000100007","volume":"9","author":"Carvalho C.E.","year":"2005","unstructured":"Carvalho C.E.; Berezin E.N.; Pistelli I.P.; M&#xED;mica L.; Cardoso M.R.A.; Prevalence of Staphylococcus aureus introduced into intensive care units of a university hospital. Braz J Infect Dis 2005,9(1),56-63","journal-title":"Braz J Infect Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/S1413-86702005000100010","volume":"9","author":"Cavalcanti S.M.M.","year":"2005","unstructured":"Cavalcanti S.M.M.; Fran&#xE7;a E.R.; Cabral C.; Prevalence of Staphylococcus aureus introduced into intensive care units of a university hospital. Braz J Infect Dis 2005,9(1),56-63","journal-title":"Braz J Infect Dis"},{"key":"ref=83","author":"Iaria S.T.","year":"1980","unstructured":"Iaria S.T.; Furlanetto S.M.; Campos M.L.;  Staphylococcus aureus research enterotoxigenic in the root handlers food in hospital, S&#xE3;o Paulo, 1976 1980","journal-title":"Staphylococcus aureus research enterotoxigenic in the root handlers food in hospital, S&#xE3;o Paulo, 1976"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM200101043440102","volume":"344","author":"von Eiff C.","year":"2001","unstructured":"von Eiff C.; Becker K.; Machka K.; Stammer H.; Peters G.; Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001,344(1),11-16","journal-title":"N Engl J Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1111\/j.1444-0903.2005.00983.x","volume":"35","author":"Roberts S.","year":"2005","unstructured":"Roberts S.; Chambers S.; Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J 2005,35(s2)(Suppl. 2),S97-S105","journal-title":"Intern Med J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1590\/S0036-36342005000500009","volume":"47","author":"Velazquez-Meza M.E.","year":"2005","unstructured":"Velazquez-Meza M.E.; Emergence and spread of methicillinresistant Staphylococcus aureus. Public Health Mex 2005,47(5),381-387","journal-title":"Public Health Mex"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/0002-9343(65)90100-2","volume":"39","author":"Cluff L.E.","year":"1965","unstructured":"Cluff L.E.; Reynolds R.J.; Management of staphylococcal infections. Am J Med 1965,39(5),812-825","journal-title":"Am J Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archinte.1995.00430110069007","volume":"155","author":"Malanoski G.J.","year":"1995","unstructured":"Malanoski G.J.; Samore M.H.; Pefanis A.; Karchmer A.W.; Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995,155(11),1161-1166","journal-title":"Arch Intern Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/archinte.1995.00430150125013","volume":"155","author":"Mathew J.","year":"1995","unstructured":"Mathew J.; Addai T.; Anand A.; Morrobel A.; Maheshwari P.; Freels S.; Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995,155(15),1641-1648","journal-title":"Arch Intern Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1111\/j.1444-0903.2005.00979.x","volume":"35","author":"Gosbell I.B.","year":"2005","unstructured":"Gosbell I.B.; Diagnosis and management of catheter-related bloodstream infections due to Staphylococcus aureus. Intern Med J 2005,35(s2)(Suppl. 2),S45-S62","journal-title":"Intern Med J"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0002-9343(88)80337-1","volume":"85","author":"Jacobson M.A.","year":"1988","unstructured":"Jacobson M.A.; Gellermann H.; Chambers H.; Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and aids-related complex. Am J Med 1988,85(2),172-176","journal-title":"Am J Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"Tong S.Y.C.","year":"2015","unstructured":"Tong S.Y.C.; Davis J.S.; Eichenberger E.; Holland T.L.; Fowler V.G.; Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015,28(3),603-661","journal-title":"Clin Microbiol Rev"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/cid\/ciaa109","volume":"71","author":"McGuire E.","year":"2020","unstructured":"McGuire E.; Boyd A.; Woods K.; Staphylococcus aureus Bacteremia. Clin Infect Dis 2020,71(10),2765-2766","journal-title":"Clin Infect Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"7.2.29","DOI":"10.1128\/microbiolspec.GPP3-0031-2018","volume":"7","author":"Jenul C","year":"2019","unstructured":"Jenul C; Horswill AR; Regulation of Staphylococcus aureus Virulence. Microbiol Spectr 2019,7(2),7.2.29","journal-title":"Microbiol Spectr"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jdermsci.2006.03.011","volume":"42","author":"Iwatsuki K.","year":"2006","unstructured":"Iwatsuki K.; Yamasaki O.; Morizane S.; Oono T.; Staphylococcal cutaneous infections: Invasion, evasion and aggression. J Dermatol Sci 2006,42(3),203-214","journal-title":"J Dermatol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nm991","volume":"10","author":"Weidenmaier C.","year":"2004","unstructured":"Weidenmaier C.; Kokai-Kun J.F.; Kristian S.A.; Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004,10(3),243-245","journal-title":"Nat Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e00632","DOI":"10.1128\/mBio.00632-15","volume":"6","author":"Winstel V.","year":"2015","unstructured":"Winstel V.; K&#xFC;hner P.; Salomon F.; Wall teichoic acid glycosylation governs Staphylococcus aureus nasal colonization. MBio 2015,6(4),e00632-e15","journal-title":"MBio"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","volume":"2","author":"Llewelyn M.","year":"2002","unstructured":"Llewelyn M.; Cohen J.; Superantigens: Microbial agents that corrupt immunity. Lancet Infect Dis 2002,2(3),156-162","journal-title":"Lancet Infect Dis"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.20031636","volume":"199","author":"de Haas C.J.C.","year":"2004","unstructured":"de Haas C.J.C.; Veldkamp K.E.; Peschel A.; Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004,199(5),687-695","journal-title":"J Exp Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nm728","volume":"8","author":"Chavakis T.","year":"2002","unstructured":"Chavakis T.; Hussain M.; Kanse S.M.; Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med 2002,8(7),687-693","journal-title":"Nat Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.4049\/jimmunol.164.7.3713","volume":"164","author":"Gresham H.D.","year":"2000","unstructured":"Gresham H.D.; Lowrance J.H.; Caver T.E.; Wilson B.S.; Cheung A.L.; Lindberg F.P.; Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000,164(7),3713-3722","journal-title":"J Immunol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1172\/JCI0216318","volume":"110","author":"Lee L.Y.","year":"2002","unstructured":"Lee L.Y.; Miyamoto Y.J.; McIntyre B.W.; The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest 2002,110(10),1461-1471","journal-title":"J Clin Invest"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1574-6968.1994.tb06828.x","volume":"118","author":"Foster T.J.","year":"1994","unstructured":"Foster T.J.; McDevitt D.; Surface-associated proteins of Staphylococcus aureus: Their possible roles in virulence. FEMS Microbiol Lett 1994,118(3),199-205","journal-title":"FEMS Microbiol Lett"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrmicro1289","volume":"3","author":"Foster T.J.","year":"2005","unstructured":"Foster T.J.; Immune evasion by staphylococci. Nat Rev Microbiol 2005,3(12),948-958","journal-title":"Nat Rev Microbiol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijmm.2004.06.016","volume":"294","author":"Fedtke I.","year":"2004","unstructured":"Fedtke I.; G&#xF6;tz F.; Peschel A.; Bacterial evasion of innate host defenses-the Staphylococcus aureus lesson. Int J Med Microbiol 2004,294(2-3),189-194","journal-title":"Int J Med Microbiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/pathogens4040826","volume":"4","author":"Flannagan R.","year":"2015","unstructured":"Flannagan R.; Heit B.; Heinrichs D.; Antimicrobial mechanisms of macrophages and the immune evasion strategies of Staphylococcus aureus. Pathogens 2015,4(4),826-868","journal-title":"Pathogens"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.meegid.2013.03.013","volume":"21","author":"Grumann D.","year":"2014","unstructured":"Grumann D.; N&#xFC;bel U.; Br&#xF6;ker B.M.; Staphylococcus aureus toxins-Their functions and genetics. Infect Genet Evol 2014,21,583-592","journal-title":"Infect Genet Evol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/CMR.13.1.16","volume":"13","author":"Dinges M.M.","year":"2000","unstructured":"Dinges M.M.; Orwin P.M.; Schlievert P.M.; Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000,13(1),16-34","journal-title":"Clin Microbiol Rev"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"Bush K.","year":"2010","unstructured":"Bush K.; Jacoby G.A.; Updated functional classification of &#x3B2;-lactamases. Antimicrob Agents Chemother 2010,54(3),969-976","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12272-020-01246-x","volume":"43","author":"Chang J.","year":"2020","unstructured":"Chang J.; Lee R.E.; Lee W.; A pursuit of Staphylococcus aureus continues: A role of persister cells. Arch Pharm Res 2020,43(6),630-638","journal-title":"Arch Pharm Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"Lee A.S.","year":"2018","unstructured":"Lee A.S.; De Lencastre H.; Garau J.; Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Prim 2018,4,18033","journal-title":"Nat Rev Dis Prim"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/cid\/cit613","volume":"58","author":"Stryjewski M.E.","year":"2014","unstructured":"Stryjewski M.E.; Corey G.R.; Methicillin-resistant Staphylococcus aureus: An evolving pathogen. Clin Infect Dis 2014,58(Suppl. 1),S10-S19","journal-title":"Clin Infect Dis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"Turner N.A.","year":"2019","unstructured":"Turner N.A.; Sharma-Kuinkel B.K.; Maskarinec S.A.; Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat Rev Microbiol 2019,17(4),203-218","journal-title":"Nat Rev Microbiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/CMR.00002-11","volume":"24","author":"Marshall B.M.","year":"2011","unstructured":"Marshall B.M.; Levy S.B.; Food animals and antimicrobials: Impacts on human health. Clin Microbiol Rev 2011,24(4),718-733","journal-title":"Clin Microbiol Rev"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.mib.2010.08.005","volume":"13","author":"Wright G.D.","year":"2010","unstructured":"Wright G.D.; Antibiotic resistance in the environment: A link to the clinic? Curr Opin Microbiol 2010,13(5),589-594","journal-title":"Curr Opin Microbiol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mib.2007.08.009","volume":"10","author":"D\u2019Costa V.M.","year":"2007","unstructured":"D\u2019Costa V.M.; Griffiths E.; Wright G.D.; Expanding the soil antibiotic resistome: Exploring environmental diversity. Curr Opin Microbiol 2007,10(5),481-489","journal-title":"Curr Opin Microbiol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1574-6968.2007.00757.x","volume":"271","author":"Aminov R.I.","year":"2007","unstructured":"Aminov R.I.; Mackie R.I.; Evolution and ecology of antibiotic resistance genes. FEMS Microbiol Lett 2007,271(2),147-161","journal-title":"FEMS Microbiol Lett"},{"key":"ref=118","author":"Silbergeld E.K.","year":"2008","unstructured":"Silbergeld E.K.; Graham J.; Price L.B.; Industrial food animal production, antimicrobial resistance, and human health. Annual Review of Public Health 2008","journal-title":"Annual Review of Public Health"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"D517","DOI":"10.1093\/nar\/gkz1136","volume":"48","author":"Alcock B.P.","year":"2020","unstructured":"Alcock B.P.; Raphenya A.R.; Lau T.T.Y.; CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res 2020,48(D1),D517-D525","journal-title":"Nucleic Acids Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"e1619","DOI":"10.1371\/journal.pone.0001619","volume":"3","author":"Fajardo A.","year":"2008","unstructured":"Fajardo A.; Mart&#xED;nez-Mart&#xED;n N.; Mercadillo M.; The neglected intrinsic resistome of bacterial pathogens. PLoS One 2008,3(2),e1619","journal-title":"PLoS One"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijmm.2013.02.009","volume":"303","author":"Cox G.","year":"2013","unstructured":"Cox G.; Wright G.D.; Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions. Int J Med Microbiol 2013,303(6-7),287-292","journal-title":"Int J Med Microbiol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrmicro1614","volume":"5","author":"Wright G.D.","year":"2007","unstructured":"Wright G.D.; The antibiotic resistome: The nexus of chemical and genetic diversity. Nat Rev Microbiol 2007,5(3),175-186","journal-title":"Nat Rev Microbiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mib.2012.07.004","volume":"15","author":"Dantas G.","year":"2012","unstructured":"Dantas G.; Sommer M.O.A.; Context matters-the complex interplay between resistome genotypes and resistance phenotypes. Curr Opin Microbiol 2012,15(5),577-582","journal-title":"Curr Opin Microbiol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"6.1.06","DOI":"10.1128\/microbiolspec.MTBP-0006-2016","volume":"6","author":"Mart&#xED;nez JL","year":"2018","unstructured":"Mart&#xED;nez JL; Ecology and evolution of chromosomal gene transfer between environmental microorganisms and pathogens. Microbiol Spectr 2018,6(1),6.1.06","journal-title":"Microbiol Spectr"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3389\/fmicb.2018.02928","volume":"9","author":"Peterson E.","year":"2018","unstructured":"Peterson E.; Kaur P.; Antibiotic resistance mechanisms in bacteria: Relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol 2018,9,2928","journal-title":"Front Microbiol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1039\/c0cc05111j","volume":"47","author":"Wright G.D.","year":"2011","unstructured":"Wright G.D.; Molecular mechanisms of antibiotic resistance. Chem Commun (Camb) 2011,47(14),4055-4061","journal-title":"Chem Commun (Camb)"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/iub.1289","volume":"66","author":"Fishovitz J.","year":"2014","unstructured":"Fishovitz J.; Hermoso J.A.; Chang M.; Mobashery S.; Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life 2014,66(8),572-577","journal-title":"IUBMB Life"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.micpath.2016.10.028","volume":"101","author":"Liu J.","year":"2016","unstructured":"Liu J.; Chen D.; Peters B.M.; Staphylococcal chromosomal cassettes mec (SCCmec): A mobile genetic element in methicillin-resistant Staphylococcus aureus. Microb Pathog 2016,101,56-67","journal-title":"Microb Pathog"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","volume":"44","author":"Katayama Y.","year":"2000","unstructured":"Katayama Y.; Ito T.; Hiramatsu K.; A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000,44(6),1549-1555","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pro.2424","volume":"23","author":"Kumar N.","year":"2014","unstructured":"Kumar N.; Radhakrishnan A.; Wright C.C.; Crystal structure of the transcriptional regulator Rv1219c of Mycobacterium tuberculosis. Protein Sci 2014,23(4),423-432","journal-title":"Protein Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","volume":"45","author":"Vester B.","year":"2001","unstructured":"Vester B.; Douthwaite S.; Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001,45(1),1-12","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/AAC.39.3.577","volume":"39","author":"Weisblum B.","year":"1995","unstructured":"Weisblum B.; Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995,39(3),577-585","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1128\/AAC.00131-06","volume":"50","author":"Long K.S.","year":"2006","unstructured":"Long K.S.; Poehlsgaard J.; Kehrenberg C.; Schwarz S.; Vester B.; The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006,50(7),2500-2505","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","volume":"43","author":"Roberts M.C.","year":"1999","unstructured":"Roberts M.C.; Sutcliffe J.; Courvalin P.; Jensen L.B.; Rood J.; Seppala H.; Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999,43(12),2823-2830","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/j.1365-2958.2005.04754.x","volume":"57","author":"Kehrenberg C.","year":"2005","unstructured":"Kehrenberg C.; Schwarz S.; Jacobsen L.; Hansen L.H.; Vester B.; A new mechanism for chloramphenicol, florfenicol and clindamycin re-sistance: Methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005,57(4),1064-1073","journal-title":"Mol Microbiol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/antibiotics3040572","volume":"3","author":"Binda E.","year":"2014","unstructured":"Binda E.; Marinelli F.; Marcone G.; Old and new glycopeptide antibiotics: Action and resistance. Antibiotics 2014,3(4),572-594","journal-title":"Antibiotics"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"10408","DOI":"10.1021\/bi00107a007","volume":"30","author":"Bugg T.D.H.","year":"1991","unstructured":"Bugg T.D.H.; Wright G.D.; Dutka-Malen S.; Arthur M.; Courvalin P.; Walsh C.T.; Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 1991,30(43),10408-10415","journal-title":"Biochemistry"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1042\/bj3041021","volume":"304","author":"Billot-Klein D.","year":"1994","unstructured":"Billot-Klein D.; Blanot D.; Gutmann L.; van Heijenoort J.; Association constants for the binding of vancomycin and teicoplanin to N-acetyl-d-alanyl-d-alanine and N-acetyl-d-alanyl-d-serine. Biochem J 1994,304(3),1021-1022","journal-title":"Biochem J"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"25265","DOI":"10.1074\/jbc.M111.226936","volume":"286","author":"Vetting M.W.","year":"2011","unstructured":"Vetting M.W.; Hegde S.S.; Wang M.; Jacoby G.A.; Hooper D.C.; Blanchard J.S.; Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem 2011,286(28),25265-25273","journal-title":"J Biol Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11373-007-9194-y","volume":"15","author":"Shakil S.","year":"2008","unstructured":"Shakil S.; Khan R.; Zarrilli R.; Khan A.U.; Aminoglycosides versus bacteria - a description of the action, resistance mechanism, and nosocomial battleground. J Biomed Sci 2008,15(1),5-14","journal-title":"J Biomed Sci"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01477-07","volume":"52","author":"Fritsche T.R.","year":"2008","unstructured":"Fritsche T.R.; Castanheira M.; Miller G.H.; Jones R.N.; Armstrong E.S.; Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother 2008,52(5),1843-1845","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/jac\/dkt078","volume":"68","author":"Hidalgo L.","year":"2013","unstructured":"Hidalgo L.; Hopkins K.L.; Gutierrez B.; Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK. J Antimicrob Chemother 2013,68(7),1543-1550","journal-title":"J Antimicrob Chemother"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1093\/nar\/gkp575","volume":"37","author":"Savic M.","year":"2009","unstructured":"Savic M.; Lovri\u0107 J.; Tomic T.I.; Vasiljevic B.; Conn G.L.; Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlapping groups of aminoglycoside antibiotics. Nucleic Acids Res 2009,37(16),5420-5431","journal-title":"Nucleic Acids Res"},{"key":"ref=144","first-page":"2883","volume":"130","author":"Blanco M.G.","year":"1984","unstructured":"Blanco M.G.; Hardisson C.; Salas J.A.; Resistance in inhibitors of RNA polymerase in actinomycetes which produce them. J Gen Microbiol 1984,130(11),2883-2891","journal-title":"J Gen Microbiol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/146837a0","volume":"146","author":"Abraham E.P.","year":"1940","unstructured":"Abraham E.P.; Chain E.; An Enzyme from Bacteria able to Destroy Penicillin. Nature 1940,146(3713),837","journal-title":"Nature"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1099\/jmm.0.052555-0","volume":"62","author":"Johnson A.P.","year":"2013","unstructured":"Johnson A.P.; Woodford N.; Global spread of antibiotic resistance: The example of New Delhi metallo-&#x3B2;-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013,62(4),499-513","journal-title":"J Med Microbiol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/14656566.2013.763030","volume":"14","author":"Lynch J.P.","year":"2013","unstructured":"Lynch J.P.; Clark N.M.; Zhanel G.G.; Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum &#x3B2;-lactamases and carbapenemases). Expert Opin Pharmacother 2013,14(2),199-210","journal-title":"Expert Opin Pharmacother"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"Jacoby G.A.","year":"2009","unstructured":"Jacoby G.A.; AmpC &#x3B2;-Lactamases. Clin Microbiol Rev 2009,22(1),161-182","journal-title":"Clin Microbiol Rev"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1368-7646(98)80002-2","volume":"1","author":"Wiedemann B.","year":"1998","unstructured":"Wiedemann B.; Pfeifle D.; Wiegand I.; Janas E.; &#x3B2;-Lactamase induction and cell wall recycling in gram-negative bacteria. Drug Resist Updat 1998,1(4),223-226","journal-title":"Drug Resist Updat"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","volume":"57","author":"Wright G.","year":"2005","unstructured":"Wright G.; Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv Drug Deliv Rev 2005,57(10),1451-1470","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/pro.2273","volume":"22","author":"Norris A.L.","year":"2013","unstructured":"Norris A.L.; Serpersu E.H.; Ligand promiscuity through the eyes of the aminoglycoside N 3 acetyltransferase IIa. Protein Sci 2013,22(7),916-928","journal-title":"Protein Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"Ramirez M.S.","year":"2010","unstructured":"Ramirez M.S.; Tolmasky M.E.; Aminoglycoside modifying enzymes. Drug Resist Updat 2010,13(6),151-171","journal-title":"Drug Resist Updat"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","volume":"67","author":"Nikaido H.","year":"2003","unstructured":"Nikaido H.; Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003,67(4),593-656","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12257-011-0151-2","volume":"7","author":"Choi HJ","year":"2012","unstructured":"Choi HJ; Kim DW; Choi YW; Broad-spectrum In vitro antimicrobial activities of Streptomyces sp. strain BCNU 1001. Biotechnol Bioproc E1 2012,7(3),576-583","journal-title":"Biotechnol Bioproc E1"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"E2629","DOI":"10.1073\/pnas.1310333110","volume":"110","author":"Kojima S.","year":"2013","unstructured":"Kojima S.; Nikaido H.; Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci USA 2013,110(28),E2629-E2634","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijmm.2011.10.001","volume":"302","author":"Li H.","year":"2012","unstructured":"Li H.; Luo Y.F.; Williams B.J.; Blackwell T.S.; Xie C.M.; Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies. Int J Med Microbiol 2012,302(2),63-68","journal-title":"Int J Med Microbiol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2741\/1075","volume":"8","author":"Hancock R.E.W.","year":"2003","unstructured":"Hancock R.E.W.; Hancock R.E.W.; On the mechanism of solute uptake in Pseudomonas. Front Biosci 2003,8(6),1075","journal-title":"Front Biosci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/jac\/dkt044","volume":"68","author":"T&#xE4;ngd&#xE9;n T.","year":"2013","unstructured":"T&#xE4;ngd&#xE9;n T.; Adler M.; Cars O.; Sandegren L.; L&#xF6;wdin E.; Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother 2013,68(6),1319-1326","journal-title":"J Antimicrob Chemother"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10096-012-1665-z","volume":"31","author":"Novais &#xC2;.","year":"2012","unstructured":"Novais &#xC2;.; Rodrigues C.; Branquinho R.; Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur J Clin Microbiol Infect Dis 2012,31(11),3057-3063","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbapap.2008.10.004","volume":"1794","author":"Nikaido H.","year":"2009","unstructured":"Nikaido H.; Takatsuka Y.; Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta Proteins Proteomics 2009,1794(5),769-781","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.femsle.2005.02.034","volume":"245","author":"Roberts M.C.","year":"2005","unstructured":"Roberts M.C.; Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005,245(2),195-203","journal-title":"FEMS Microbiol Lett"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1128\/AAC.34.8.1611","volume":"34","author":"Bismuth R.","year":"1990","unstructured":"Bismuth R.; Zilhao R.; Sakamoto H.; Guesdon J.L.; Courvalin P.; Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother 1990,34(8),1611-1614","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1128\/JB.182.11.3142-3150.2000","volume":"182","author":"Lee A.","year":"2000","unstructured":"Lee A.; Mao W.; Warren M.S.; Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000,182(11),3142-3150","journal-title":"J Bacteriol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/AAC.49.1.161-169.2005","volume":"49","author":"Kaatz G.W.","year":"2005","unstructured":"Kaatz G.W.; Thyagarajan R.V.; Seo S.M.; Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob Agents Chemother 2005,49(1),161-169","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2958.2008.06424.x","volume":"70","author":"Warner D.M.","year":"2008","unstructured":"Warner D.M.; Shafer W.M.; Jerse A.E.; Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrDMtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008,70(2),462-478","journal-title":"Mol Microbiol"},{"key":"ref=166","first-page":"267","volume":"238","author":"Olliver A.","year":"2004","unstructured":"Olliver A.; Vall&#xE9; M.; Chaslus-Dancla E.; Cloeckaert A.; Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol Lett 2004,238(1),267-272","journal-title":"FEMS Microbiol Lett"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1128\/AAC.45.5.1550-1552.2001","volume":"45","author":"Webber M.A.","year":"2001","unstructured":"Webber M.A.; Piddock L.J.V.; Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother 2001,45(5),1550-1552","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00284-012-0215-3","volume":"66","author":"Wang K.","year":"2013","unstructured":"Wang K.; Pei H.; Huang B.; The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China. Curr Microbiol 2013,66(3),222-226","journal-title":"Curr Microbiol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/ncomms3078","volume":"4","author":"Yamasaki S.","year":"2013","unstructured":"Yamasaki S.; Nikaido E.; Nakashima R.; The crystal structure of multidrug-resistance regulator RamR with multiple drugs. Nat Commun 2013,4(1),2078","journal-title":"Nat Commun"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"e00446","DOI":"10.1128\/mBio.00446-12","volume":"3","author":"Zalucki Y.M.","year":"2012","unstructured":"Zalucki Y.M.; Dhulipala V.; Shafer W.M.; Dueling regulatory properties of a transcriptional activator (MtrA) and repressor (MtrR) that con-trol efflux pump gene expression in Neisseria gonorrhoeae. MBio 2012,3(6),e00446-e12","journal-title":"MBio"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/jac\/dku140","volume":"69","author":"Baucheron S.","year":"2014","unstructured":"Baucheron S.; Nishino K.; Monchaux I.; Bile-mediated activation of the acrAB and tolC multidrug efflux genes occurs mainly through transcriptional derepression of ramA in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2014,69(9),2400-2406","journal-title":"J Antimicrob Chemother"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1365-2958.2004.04449.x","volume":"55","author":"Hirakawa H.","year":"2005","unstructured":"Hirakawa H.; Inazumi Y.; Masaki T.; Hirata T.; Yamaguchi A.; Indole induces the expression of multidrug exporter genes in Escherichia coli. Mol Microbiol 2005,55(4),1113-1126","journal-title":"Mol Microbiol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1757-4749-4-5","volume":"4","author":"Nikaido E.","year":"2012","unstructured":"Nikaido E.; Giraud E.; Baucheron S.; Effects of indole on drug resistance and virulence of Salmonella enterica serovar Typhimurium revealed by genome-wide analyses. Gut Pathog 2012,4(1),5","journal-title":"Gut Pathog"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1099\/mic.0.045757-0","volume":"157","author":"Nikaido E.","year":"2011","unstructured":"Nikaido E.; Shirosaka I.; Yamaguchi A.; Nishino K.; Regulation of the AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in response to indole and paraquat. Microbiology (Reading) 2011,157(3),648-655","journal-title":"Microbiology (Reading)"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/AAC.36.4.695","volume":"36","author":"Levy S.B.","year":"1992","unstructured":"Levy S.B.; Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992,36(4),695-703","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2014.05.090","volume":"453","author":"Sun J.","year":"2014","unstructured":"Sun J.; Deng Z.; Yan A.; Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun 2014,453(2),254-267","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.77.7.3974","volume":"77","author":"McMurry L.","year":"1980","unstructured":"McMurry L.; Petrucci R.E.; Levy S.B.; Active efflux of tetracycline encoded by four genetically different tetracyline resistance determinants in Escherichia coli. Proc Natl Acad Sci USA 1980,77(7),3974-3977","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=178","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.8.2276","author":"Benveniste R.","year":"1973","unstructured":"Benveniste R.; Davies J.; Aminoglycoside antibiotic inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic resistant bacteria. Proc Natl Acad Sci USA 1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1126\/science.8153624","volume":"264","author":"Davies J.","year":"1994","unstructured":"Davies J.; Inactivation of antibiotics and the dissemination of resistance genes. Science 1994,264(5157),375-382","journal-title":"Science"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jac\/20.3.452","volume":"20","author":"Mart&#xED;nez-Su&#xE1;rez J.V.","year":"1987","unstructured":"Mart&#xED;nez-Su&#xE1;rez J.V.; Mart&#xED;nez J.L.; Goicoechea M.J.L.D.; Acquisition of antibiotic resistance plasmids in vivo by extraintestinal Salmonella spp. J Antimicrob Chemother 1987,20(3),452-453","journal-title":"J Antimicrob Chemother"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1574-6976.2008.00142.x","volume":"33","author":"Martinez J.L.","year":"2009","unstructured":"Martinez J.L.; Fajardo A.; Garmendia L.; A global view of antibiotic resistance. FEMS Microbiol Rev 2009,33(1),44-65","journal-title":"FEMS Microbiol Rev"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1574-6976.2008.00157.x","volume":"33","author":"Martinez J.L.","year":"2009","unstructured":"Martinez J.L.; S&#xE1;nchez M.B.; Mart&#xED;nez-Solano L.; Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 2009,33(2),430-449","journal-title":"FEMS Microbiol Rev"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0006-2952(00)00291-4","volume":"60","author":"Van Bambeke F.","year":"2000","unstructured":"Van Bambeke F.; Balzi E.; Tulkens P.M.; Antibiotic efflux pumps. Biochem Pharmacol 2000,60(4),457-470","journal-title":"Biochem Pharmacol"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkg050","volume":"51","author":"Webber M.A.","year":"2003","unstructured":"Webber M.A.; Piddock L.J.V.; The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003,51(1),9-11","journal-title":"J Antimicrob Chemother"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","volume":"78","author":"Nikaido H.","year":"2009","unstructured":"Nikaido H.; Multidrug resistance in bacteria. Annu Rev Biochem 2009,78(1),119-146","journal-title":"Annu Rev Biochem"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"22","author":"Cannon R.D.","year":"2009","unstructured":"Cannon R.D.; Lamping E.; Holmes A.R.; Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009,22(2),291-321","journal-title":"Clin Microbiol Rev"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jac\/dkg225","volume":"51","author":"Van Bambeke F.","year":"2003","unstructured":"Van Bambeke F.; Michot J.M.; Tulkens P.M.; Antibiotic efflux pumps in eukaryotic cells: Occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. J Antimicrob Chemother 2003,51(5),1067-1077","journal-title":"J Antimicrob Chemother"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1086\/320195","volume":"183","author":"Babiker H.A.","year":"2001","unstructured":"Babiker H.A.; Pringle S.J.; Abdel-Muhsin A.; Mackinnon M.; Hunt P.; Walliker D.; High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis 2001,183(10),1535-1538","journal-title":"J Infect Dis"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/10495390600957092","volume":"17","author":"Harbottle H.","year":"2006","unstructured":"Harbottle H.; Thakur S.; Zhao S.; White D.G.; Genetics of antimicrobial resistance. Anim Biotechnol 2006,17(2),111-124","journal-title":"Anim Biotechnol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"e00227","DOI":"10.1128\/genomeA.00227-12","volume":"1","author":"Kumar S.","year":"2013","unstructured":"Kumar S.; Lindquist I.E.; Sundararajan A.; Genome Sequence of Non-O1 Vibrio Cholerae PS15. Genome Announc 2013,1(1),e00227-e12","journal-title":"Genome Announc"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijantimicag.2008.03.017","volume":"32","author":"Biswas S.","year":"2008","unstructured":"Biswas S.; Raoult D.; Rolain J.M.; A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis. Int J Antimicrob Agents 2008,32(3),207-220","journal-title":"Int J Antimicrob Agents"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/17460441.2010.497535","volume":"5","author":"Wright G.D.","year":"2010","unstructured":"Wright G.D.; The antibiotic resistome. Expert Opin Drug Discov 2010,5(8),779-788","journal-title":"Expert Opin Drug Discov"},{"key":"ref=193","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.0711939105","volume":"105","author":"Baysarowich J.","year":"2008","unstructured":"Baysarowich J.; Koteva K.; Hughes D.W.; Rifamycin antibiotic resistance by adp-ribosylation: Structure and diversity of arr. Proc Natl Acad Sci USA 2008,105(12),4886-4891","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2010.11.052","volume":"144","author":"Nichols R.J.","year":"2011","unstructured":"Nichols R.J.; Sen S.; Choo Y.J.; Phenotypic landscape of a bacterial cell. Cell 2011,144(1),143-156","journal-title":"Cell"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"9051","DOI":"10.1073\/pnas.0902400106","volume":"106","author":"Tal N.","year":"2009","unstructured":"Tal N.; Schuldiner S.; A coordinated network of transporters with overlapping specificities provides a robust survival strategy. Proc Natl Acad Sci USA 2009,106(22),9051-9056","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=196","author":"Poole K.","year":"2005","unstructured":"Poole K.; Srikumar R.; Multidrug efflux in Pseudomonas aeruginosa components, mechanisms and clinical significance. Curr Top Med Chem 2005","journal-title":"Curr Top Med Chem"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00249-017-1238-2","volume":"46","author":"Rahman T.","year":"2017","unstructured":"Rahman T.; Yarnall B.; Doyle D.A.; Efflux drug transporters at the forefront of antimicrobial resistance. Eur Biophys J 2017,46(7),647-653","journal-title":"Eur Biophys J"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/CMR.00048-19","volume":"33","author":"Gandra S.","year":"2020","unstructured":"Gandra S.; Alvarez-Uria G.; Turner P.; Joshi J.; Limmathurotsakul D.; van Doorn H.R.; Antimicrobial resistance surveillance in low- and middle-income countries: Progress and challenges in eight South Asian and Southeast Asian countries. Clin Microbiol Rev 2020,33(3),e00048-e19","journal-title":"Clin Microbiol Rev"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.45.2.428-432.2001","volume":"45","author":"Chuanchuen R.","year":"2001","unstructured":"Chuanchuen R.; Beinlich K.; Hoang T.T.; Becher A.; Karkhoff-Schweizer R.R.; Schweizer H.P.; Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: Exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001,45(2),428-432","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/AAC.43.5.1301","volume":"43","author":"Nakae T.","year":"1999","unstructured":"Nakae T.; Nakajima A.; Ono T.; Saito K.; Yoneyama H.; Resistance to &#x3B2;-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and &#x3B2;-lactamase. Antimicrob Agents Chemother 1999,43(5),1301-1303","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","volume":"46","author":"Nakajima A.","year":"2002","unstructured":"Nakajima A.; Sugimoto Y.; Yoneyama H.; Nakae T.; High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol 2002,46(6),391-395","journal-title":"Microbiol Immunol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/AAC.31.4.582","volume":"31","author":"Hirai K.","year":"1987","unstructured":"Hirai K.; Suzue S.; Irikura T.; Iyobe S.; Mitsuhashi S.; Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1987,31(4),582-586","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1098\/rspb.2009.0320","volume":"276","author":"Martinez J.L.","year":"2009","unstructured":"Martinez J.L.; The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc Biol Sci 2009,276(1667),2521-2530","journal-title":"Proc Biol Sci"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmicb.2013.00007","volume":"4","author":"Alvarez-Ortega C.","year":"2013","unstructured":"Alvarez-Ortega C.; Olivares J.; Mart&#xED;nez J.L.; RND multidrug efflux pumps: What are they good for? Front Microbiol 2013,4,7","journal-title":"Front Microbiol"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0168-6445(03)00048-2","volume":"27","author":"Nies D.H.","year":"2003","unstructured":"Nies D.H.; Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol Rev 2003,27(2-3),313-339","journal-title":"FEMS Microbiol Rev"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2958.2000.01926.x","volume":"37","author":"Zgurskaya H.I.","year":"2000","unstructured":"Zgurskaya H.I.; Nikaido H.; Multidrug resistance mechanisms: Drug efflux across two membranes. Mol Microbiol 2000,37(2),219-225","journal-title":"Mol Microbiol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.micro.56.012302.161038","volume":"56","author":"Ramos J.L.","year":"2002","unstructured":"Ramos J.L.; Duque E.; Gallegos M.T.; Mechanisms of solvent tolerance in gram-negative bacteria. Annu Rev Microbiol 2002,56(1),743-768","journal-title":"Annu Rev Microbiol"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/IAI.71.8.4250-4259.2003","volume":"71","author":"Lin J.","year":"2003","unstructured":"Lin J.; Sahin O.; Michel L.O.; Zhang Q.; Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003,71(8),4250-4259","journal-title":"Infect Immun"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1128\/IAI.69.7.4681-4685.2001","volume":"69","author":"Bina J.E.","year":"2001","unstructured":"Bina J.E.; Mekalanos J.J.; Vibrio Cholerae tolC is required for bile resistance and colonization. Infect Immun 2001,69(7),4681-4685","journal-title":"Infect Immun"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1099\/mic.0.26769-0","volume":"150","author":"Prouty A.M.","year":"2004","unstructured":"Prouty A.M.; Brodsky I.E.; Falkow S.; Gunn J.S.; Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology 2004,150(4),775-783","journal-title":"Microbiology"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1574-6968.1996.tb07983.x","volume":"135","author":"Lacroix F.J.C.","year":"1996","unstructured":"Lacroix F.J.C.; Cloeckaert A.; Gr&#xE9;pinet O.; Salmonella typhimurium acrB-like gene: Identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol Lett 1996,135(2-3),161-167","journal-title":"FEMS Microbiol Lett"},{"key":"ref=212","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.biochem.73.011303.074104","volume":"73","author":"Koronakis V.","year":"2004","unstructured":"Koronakis V.; Eswaran J.; Hughes C.; Structure and function of TolC: The bacterial exit duct for proteins and drugs. Annu Rev Biochem 2004,73,467-489","journal-title":"Annu Rev Biochem"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1128\/JB.188.3.1191-1195.2006","volume":"188","author":"Elkins C.A.","year":"2006","unstructured":"Elkins C.A.; Mullis L.B.; Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J Bacteriol 2006,188(3),1191-1195","journal-title":"J Bacteriol"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1094\/MPMI.2004.17.1.43","volume":"17","author":"Burse A.","year":"2004","unstructured":"Burse A.; Weingart H.; Ullrich M.S.; The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol Plant Microbe Interact 2004,17(1),43-54","journal-title":"Mol Plant Microbe Interact"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2958.2005.04940.x","volume":"59","author":"Nishino K.","year":"2006","unstructured":"Nishino K.; Latifi T.; Groisman E.A.; Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 2006,59(1),126-141","journal-title":"Mol Microbiol"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1365-2958.1995.mmi_17040701.x","volume":"17","author":"Stone B.J.","year":"1995","unstructured":"Stone B.J.; Miller V.L.; Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB\/c mice. Mol Microbiol 1995,17(4),701-712","journal-title":"Mol Microbiol"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1462-5822.2005.00671.x","volume":"8","author":"Buckley A.M.","year":"2006","unstructured":"Buckley A.M.; Webber M.A.; Cooles S.; The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 2006,8(5),847-856","journal-title":"Cell Microbiol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1084\/jem.20020005","volume":"196","author":"Hirakata Y.","year":"2002","unstructured":"Hirakata Y.; Srikumar R.; Poole K.; Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med 2002,196(1),109-118","journal-title":"J Exp Med"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1128\/IAI.71.10.5576-5582.2003","volume":"71","author":"Jerse A.E.","year":"2003","unstructured":"Jerse A.E.; Sharma N.D.; Simms A.N.; Crow E.T.; Snyder L.A.; Shafer W.M.; A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun 2003,71(10),5576-5582","journal-title":"Infect Immun"},{"key":"ref=220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s004300050016","volume":"185","author":"Koronakis V.","year":"1996","unstructured":"Koronakis V.; Hughes C.; Synthesis, maturation and export of the E. coli hemolysin. Med Microbiol Immunol 1996,185(2),65-71","journal-title":"Med Microbiol Immunol"},{"key":"ref=221","author":"Binet R.","year":"1997","unstructured":"Binet R.; L&#xE9;toff&#xE9; S.; Ghigo J.M.; Delepelaire P.; Wandersman C.; Protein Secretion by Gram-Negative Bacterial ABC exporters-a review. Gene 1997","journal-title":"Gene"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1101\/gad.896801","volume":"15","author":"Lee V.T.","year":"2001","unstructured":"Lee V.T.; Schneewind O.; Protein secretion and the pathogenesis of bacterial infections. Genes Dev 2001,15(14),1725-1752","journal-title":"Genes Dev"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00144740","volume":"4","author":"Bhakdi S.","year":"1988","unstructured":"Bhakdi S.; Mackman N.; Menestrina G.; The hemolysin of Escherichia coli. Eur J Epidemiol 1988,4(2),135-143","journal-title":"Eur J Epidemiol"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/j.1460-2075.1990.tb07606.x","volume":"9","author":"Gilson L.","year":"1990","unstructured":"Gilson L.; Mahanty H.K.; Kolter R.; Genetic analysis of an MDR-like export system: The secretion of colicin V. EMBO J 1990,9(12),3875-3884","journal-title":"EMBO J"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1128\/JB.186.23.8137-8143.2004","volume":"186","author":"Boardman B.K.","year":"2004","unstructured":"Boardman B.K.; Fullner Satchell K.J.; Vibrio Cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol 2004,186(23),8137-8143","journal-title":"J Bacteriol"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1098\/rstb.2008.0125","volume":"364","author":"Locher K.P.","year":"2009","unstructured":"Locher K.P.; Structure and mechanism of ATP-binding cassette transporters. Philos Trans R Soc Lond B Biol Sci 2009,364(1514),239-245","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","volume":"13","author":"Szak&#xE1;cs G.","year":"2008","unstructured":"Szak&#xE1;cs G.; V&#xE1;radi A.; &#xD6;zvegy-Laczka C.; Sarkadi B.; The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 2008,13(9-10),379-393","journal-title":"Drug Discov Today"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/MMBR.00001-07","volume":"71","author":"Lubelski J.","year":"2007","unstructured":"Lubelski J.; Konings W.N.; Driessen A.J.M.; Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev 2007,71(3),463-476","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbapap.2008.11.012","volume":"1794","author":"Kuroda T.","year":"2009","unstructured":"Kuroda T.; Tsuchiya T.; Multidrug efflux transporters in the MATE family. Biochim Biophys Acta Proteins Proteomics 2009,1794(5),763-768","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/204141","volume":"2013","author":"Kumar S.","year":"2013","unstructured":"Kumar S.; Mukherjee M.M.; Varela M.F.; Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int J Bacteriol 2013,2013,1-15","journal-title":"Int J Bacteriol"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","volume":"44","author":"Yan N.","year":"2015","unstructured":"Yan N.; Structural biology of the major facilitator superfamily transporters. Annu Rev Biophys 2015,44(1),257-283","journal-title":"Annu Rev Biophys"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.micro.61.080706.093329","volume":"62","author":"Law C.J.","year":"2008","unstructured":"Law C.J.; Maloney P.C.; Wang D.N.; Ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol 2008,62(1),289-305","journal-title":"Annu Rev Microbiol"},{"key":"ref=233","author":"Saier J.","year":"2001","unstructured":"Saier J.; SMR-type multidrug resistance pumps. Curr Opin Drug Discov Devel 2001","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref=234","first-page":"107","volume":"1","author":"Tseng T.T.","year":"1999","unstructured":"Tseng T.T.; Gratwick K.S.; Kollman J.; The RND permease superfamily: An ancient, ubiquitous and diverse family that includes hu-man disease and development proteins. J Mol Microbiol Biotechnol 1999,1(1),107-125","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature13205","volume":"509","author":"Du D.","year":"2014","unstructured":"Du D.; Wang Z.; James N.R.; Structure of the AcrAB\u2013TolC multidrug efflux pump. Nature 2014,509(7501),512-515","journal-title":"Nature"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fmicb.2015.00327","volume":"6","author":"Yamaguchi A.","year":"2015","unstructured":"Yamaguchi A.; Nakashima R.; Sakurai K.; Structural basis of RND-type multidrug exporters. Front Microbiol 2015,6,327","journal-title":"Front Microbiol"},{"key":"ref=237","author":"Daury L.","year":"2016","unstructured":"Daury L.; Orange F.; Taveau J.C.; Tripartite assembly of RND multidrug efflux pumps. Nat Commun 2016","journal-title":"Nat Commun"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"e01982","DOI":"10.1128\/mBio.01982-14","volume":"6","author":"Hassan K.A.","year":"2015","unstructured":"Hassan K.A.; Liu Q.; Henderson P.J.F.; Paulsen I.T.; Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems. MBio 2015,6(1),e01982-e14","journal-title":"MBio"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1042\/EBC20160064","volume":"61","author":"Chitsaz M.","year":"2017","unstructured":"Chitsaz M.; Brown M.H.; The role played by drug efflux pumps in bacterial multidrug resistance. Essays Biochem 2017,61(1),127-139","journal-title":"Essays Biochem"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.resmic.2018.01.001","volume":"169","author":"Hassan K.A.","year":"2018","unstructured":"Hassan K.A.; Liu Q.; Elbourne L.D.H.; Pacing across the membrane: The novel PACE family of efflux pumps is widespread in Gram-negative pathogens. Res Microbiol 2018,169(7-8),450-454","journal-title":"Res Microbiol"},{"key":"ref=241","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antibiotics2010028","volume":"2","author":"Handzlik J.","unstructured":"Handzlik J.; Matys A.; Kie\u0107-Kononowicz K.; Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of grampositive bacteria S. aureus. Antibiotics ,2(1),28-45","journal-title":"Antibiotics"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1128\/JB.183.19.5639-5644.2001","volume":"183","author":"Kobayashi N.","year":"2001","unstructured":"Kobayashi N.; Nishino K.; Yamaguchi A.; Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 2001,183(19),5639-5644","journal-title":"J Bacteriol"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41467-017-01399-2","volume":"8","author":"Okada U.","year":"2017","unstructured":"Okada U.; Yamashita E.; Neuberger A.; Morimoto M.; van Veen H.W.; Murakami S.; Crystal structure of tripartite-type ABC transporter MacB from Acinetobacter baumannii. Nat Commun 2017,8(1),1336","journal-title":"Nat Commun"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1365-2958.1999.01162.x","volume":"31","author":"Brown M.H.","year":"1999","unstructured":"Brown M.H.; Paulsen I.T.; Skurray R.A.; The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol Microbiol 1999,31(1),394-395","journal-title":"Mol Microbiol"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1128\/AAC.42.7.1778","volume":"42","author":"Morita Y.","year":"1998","unstructured":"Morita Y.; Kodama K.; Shiota S.; NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Esche-richia coli. Antimicrob Agents Chemother 1998,42(7),1778-1782","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0378-1119(93)90625-D","volume":"127","author":"Bentley J.","year":"1993","unstructured":"Bentley J.; Hyatt L.S.; Ainley K.; Parish J.H.; Herbert R.B.; White G.R.; Cloning and sequence analysis of an Escherichia coli gene conferring bicyclomycin resistance. Gene 1993,127(1),117-120","journal-title":"Gene"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"8938","DOI":"10.1073\/pnas.89.19.8938","volume":"89","author":"Lomovskaya O.","year":"1992","unstructured":"Lomovskaya O.; Lewis K.; Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci USA 1992,89(19),8938-8942","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=248","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1006\/bbrc.1993.2320","volume":"196","author":"Naroditskaya V.","year":"1993","unstructured":"Naroditskaya V.; Schlosser M.J.; Fang N.Y.; Lewis K.; An E. coli gene emrd is involved in adaptation to low energy shock. Biochem Biophys Res Commun 1993,196(2),803-809","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1128\/JB.180.22.6068-6071.1998","volume":"180","author":"De Rossi E.","year":"1998","unstructured":"De Rossi E.; Branzoni M.; Cantoni R.; Milano A.; Riccardi G.; Ciferri O.; mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. J Bacteriol 1998,180(22),6068-6071","journal-title":"J Bacteriol"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1128\/AAC.37.4.761","volume":"37","author":"Paulsen I.T.","year":"1993","unstructured":"Paulsen I.T.; Littlejohn T.G.; R&#xE5;dstr&#xF6;m P.; The 3\u2032 conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother 1993,37(4),761-768","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1574-6968.1991.tb04870.x","volume":"82","author":"Purewal A.S.","year":"1991","unstructured":"Purewal A.S.; Nucleotide sequence of the ethidium efflux gene from Escherichia coli. FEMS Microbiol Lett 1991,82(2),229-232","journal-title":"FEMS Microbiol Lett"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1074\/jbc.270.12.6856","volume":"270","author":"Yerushalmi H.","year":"1995","unstructured":"Yerushalmi H.; Lebendiker M.; Schuldiner S.; EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H+ and is soluble in organic solvents. J Biol Chem 1995,270(12),6856-6863","journal-title":"J Biol Chem"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1469-0691.2004.00763.x","volume":"10","author":"Poole K.","year":"2004","unstructured":"Poole K.; Efflux-mediated multiresistance in gram-negative bacteria. Clin Microbiol Infect 2004,10(1),12-26","journal-title":"Clin Microbiol Infect"},{"key":"ref=254","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1107\/S2053230X1601298X","volume":"72","author":"Li J.","year":"2016","unstructured":"Li J.; Wehmeyer G.; Lovell S.; Battaile K.P.; Egan S.M.; 1.65 &#xC5; resolution structure of the arac-family transcriptional activator toxt from Vibrio Cholerae. Acta Crystallogr F Struct Biol Commun 2016,72(Pt 9),726-731","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","volume":"69","author":"Li X.Z.","year":"2009","unstructured":"Li X.Z.; Nikaido H.; Efflux-mediated drug resistance in bacteria: An update. Drugs 2009,69(12),1555-1623","journal-title":"Drugs"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.sbi.2015.07.015","volume":"33","author":"Du D.","year":"2015","unstructured":"Du D.; van Veen H.W.; Murakami S.; Pos K.M.; Luisi B.F.; Structure, mechanism and cooperation of bacterial multidrug transporters. Curr Opin Struct Biol 2015,33,76-91","journal-title":"Curr Opin Struct Biol"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fmicb.2015.00513","volume":"6","author":"Symmons M.F.","year":"2015","unstructured":"Symmons M.F.; Marshall R.L.; Bavro V.N.; Architecture and roles of periplasmic adaptor proteins in tripartite assemblies. Front Microbiol 2015,6,513","journal-title":"Front Microbiol"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.resmic.2018.05.003","volume":"169","author":"Neuberger A.","year":"2018","unstructured":"Neuberger A.; Du D.; Luisi B.F.; Structure and mechanism of bacterial tripartite efflux pumps. Res Microbiol 2018,169(7-8),401-413","journal-title":"Res Microbiol"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-micro-092412-155718","volume":"67","author":"Hinchliffe P.","year":"2013","unstructured":"Hinchliffe P.; Symmons M.F.; Hughes C.; Koronakis V.; Structure and operation of bacterial tripartite pumps. Annu Rev Microbiol 2013,67(1),221-242","journal-title":"Annu Rev Microbiol"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbamem.2007.02.007","volume":"1768","author":"Lorca G.L.","year":"2007","unstructured":"Lorca G.L.; Barabote R.D.; Zlotopolski V.; Transport capabilities of eleven gram-positive bacteria: Comparative genomic analyses. Biochim Biophys Acta Biomembr 2007,1768(6),1342-1366","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=261","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/AAC.43.1.187","volume":"43","author":"Gill M.J.","year":"1999","unstructured":"Gill M.J.; Brenwald N.P.; Wise R.; Identification of an efflux pump gene, pmra, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999,43(1),187-189","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=262","author":"Nikaido H.","year":"2010","unstructured":"Nikaido H.; Structure and Mechanism of RND-Type Multidrug Efflux Pumps. Adv Enzymol Relat Areas Mol Biol 2010","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"ref=263","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2728(93)90003-X","author":"Poolman B.","year":"1993","unstructured":"Poolman B.; Konings W.N.;  Secondary solute transport in bacteria 1993","journal-title":"Secondary solute transport in bacteria"},{"key":"ref=264","author":"Kr&#xE4;mer R.","year":"1994","unstructured":"Kr&#xE4;mer R.;  Functional Principles of Solute Transport Systems: Concepts and Perspectives 1994","journal-title":"Functional Principles of Solute Transport Systems: Concepts and Perspectives"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF01130216","volume":"11","author":"Henderson P.J.F.","year":"1991","unstructured":"Henderson P.J.F.; Studies of translocation catalysis. Biosci Rep 1991,11(6),477-538","journal-title":"Biosci Rep"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/0955-0674(93)90144-F","volume":"5","author":"Henderson P.J.F.","year":"1993","unstructured":"Henderson P.J.F.; The 12-transmembrane helix transporters. Curr Opin Cell Biol 1993,5(4),708-721","journal-title":"Curr Opin Cell Biol"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/mr.60.4.575-608.1996","volume":"60","author":"Paulsen I.T.","year":"1996","unstructured":"Paulsen I.T.; Brown M.H.; Skurray R.A.; Proton-dependent multidrug efflux systems. Microbiol Rev 1996,60(4),575-608","journal-title":"Microbiol Rev"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/AAC.41.12.2733","volume":"41","author":"Kaatz G.W.","year":"1997","unstructured":"Kaatz G.W.; Seo S.M.; Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1997,41(12),2733-2737","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"Piddock L.J.V.","year":"2006","unstructured":"Piddock L.J.V.; Multidrug-resistance efflux pumps? Not just for resistance. Nat Rev Microbiol 2006,4(8),629-636","journal-title":"Nat Rev Microbiol"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"Drlica K.","year":"2009","unstructured":"Drlica K.; Hiasa H.; Kerns R.; Malik M.; Mustaev A.; Zhao X.; Quinolones: Action and resistance updated. Curr Top Med Chem 2009,9(11),981-998","journal-title":"Curr Top Med Chem"},{"key":"ref=271","author":"Li X.Z.","year":"1994","unstructured":"Li X.Z.; Livermore D.M.; Nikaido H.; Role of Efflux Pump(s) in Intrinsic Resistance of Pseudomonas aeruginosa: Resistance to Tetracycline, Chloramphenicol, and Norfloxacin. Antimicrob Agents Chemother 1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1128\/jb.175.22.7363-7372.1993","volume":"175","author":"Poole K.","year":"1993","unstructured":"Poole K.; Krebes K.; McNally C.; Neshat S.; Multiple antibiotic resistance in Pseudomonas aeruginosa: Evidence for involvement of an efflux operon. J Bacteriol 1993,175(22),7363-7372","journal-title":"J Bacteriol"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"9ii","DOI":"10.1093\/jac\/dkg249","volume":"51","author":"Livermore DM","year":"2003","unstructured":"Livermore DM; Linezolid in vitro: Mechanism and antibacterial spectrum. J Antimicrob Chemother 2003,51(90002)(Suppl. 2),9ii-16","journal-title":"J Antimicrob Chemother"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","volume":"8","author":"Higgins C.F.","year":"1992","unstructured":"Higgins C.F.; ABC transporters: From microorganisms to man. Annu Rev Cell Biol 1992,8(1),67-113","journal-title":"Annu Rev Cell Biol"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1128\/mr.57.4.995-1017.1993","volume":"57","author":"Fath M.J.","year":"1993","unstructured":"Fath M.J.; Kolter R.; ABC transporters: Bacterial exporters. Microbiol Rev 1993,57(4),995-1017","journal-title":"Microbiol Rev"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.tibs.2009.06.004","volume":"34","author":"Jones P.M.","year":"2009","unstructured":"Jones P.M.; O\u2019Mara M.L.; George A.M.; ABC transporters: A riddle wrapped in a mystery inside an enigma. Trends Biochem Sci 2009,34(10),520-531","journal-title":"Trends Biochem Sci"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrm2646","volume":"10","author":"Rees D.C.","year":"2009","unstructured":"Rees D.C.; Johnson E.; Lewinson O.; ABC transporters: The power to change. Nat Rev Mol Cell Biol 2009,10(3),218-227","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1074\/jbc.271.16.9240","volume":"271","author":"Kast C.","year":"1996","unstructured":"Kast C.; Canfield V.; Levenson R.; Gros P.; Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J Biol Chem 1996,271(16),9240-9248","journal-title":"J Biol Chem"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1073\/pnas.93.20.10668","volume":"93","author":"Van Veen H.W.","year":"1996","unstructured":"Van Veen H.W.; Venema K.; Bolhuis H.; Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci USA 1996,93(20),10668-10672","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"34449","DOI":"10.1074\/jbc.M404072200","volume":"279","author":"Lubelski J.","year":"2004","unstructured":"Lubelski J.; Mazurkiewicz P.; van Merkerk R.; Konings W.N.; Driessen A.J.M.; ydaG and ydbA of Lactococcus lactis encode a heterodimeric ATP-binding cassette-type multidrug transporter. J Biol Chem 2004,279(33),34449-34455","journal-title":"J Biol Chem"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1128\/AAC.47.8.2413-2417.2003","volume":"47","author":"Huda N.","year":"2003","unstructured":"Huda N.; Lee E.W.; Chen J.; Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio Cholerae. Antimicrob Agents Chemother 2003,47(8),2413-2417","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1365-2958.1998.00915.x","volume":"29","author":"Ehrmann M.","year":"1998","unstructured":"Ehrmann M.; Ehrle R.; Hofmann E.; Boos W.; Schl&#xF6;sser A.; The ABC maltose transporter. Mol Microbiol 1998,29(3),685-694","journal-title":"Mol Microbiol"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/jmbi.1994.1472","volume":"241","author":"Alloing G.","year":"1994","unstructured":"Alloing G.; de Philip P.; Claverys J.P.; Three highly homologous membrane-bound lipoproteins participate in oligopeptide transport by the Ami system of the gram-positive Streptococcus pneumoniae. J Mol Biol 1994,241(1),44-58","journal-title":"J Mol Biol"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-1119(96)00541-0","volume":"183","author":"Ross J.I.","year":"1996","unstructured":"Ross J.I.; Eady E.A.; Cove J.H.; Baumberg S.; Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 1996,183(1-2),143-148","journal-title":"Gene"},{"key":"ref=285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/PL00006442","volume":"48","author":"Saurin W.","year":"1999","unstructured":"Saurin W.; Hofnung M.; Dassa E.; Getting in or out: Early segregation between importers and exporters in the evolution of ATP-Binding Cassette (ABC) transporters. J Mol Evol 1999,48(1),22-41","journal-title":"J Mol Evol"},{"key":"ref=286","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s000180050024","volume":"56","author":"K&#xF6;hler T.","year":"1999","unstructured":"K&#xF6;hler T.; Pech&#xE8;re J.C.; Pl&#xE9;siat P.; Bacterial antibiotic efflux systems of medical importance. CMLS. Cell Mol Life Sci 1999,56,771-778","journal-title":"Cell Mol Life Sci"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/MMBR.00031-07","volume":"72","author":"Davidson A.L.","year":"2008","unstructured":"Davidson A.L.; Dassa E.; Orelle C.; Chen J.; Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 2008,72(2),317-364","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0924-8579(03)00203-6","volume":"22","author":"Lage H.","year":"2003","unstructured":"Lage H.; ABC-transporters: Implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 2003,22(3),188-199","journal-title":"Int J Antimicrob Agents"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"24123","DOI":"10.1074\/jbc.271.39.24123","volume":"271","author":"Bolhuis H.","year":"1996","unstructured":"Bolhuis H.; van Veen H.W.; Brands J.R.; Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J Biol Chem 1996,271(39),24123-24128","journal-title":"J Biol Chem"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"17933","DOI":"10.1074\/jbc.273.28.17933","volume":"273","author":"Kaur P.","year":"1998","unstructured":"Kaur P.; Russell J.; Biochemical coupling between the DrrA and DrrB proteins of the doxorubicin efflux pump of Streptomyces peucetius. J Biol Chem 1998,273(28),17933-17939","journal-title":"J Biol Chem"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1365-2958.1990.tb00696.x","volume":"4","author":"Ross J.I.","year":"1990","unstructured":"Ross J.I.; Eady E.A.; Cove J.H.; Cunliffe W.J.; Baumberg S.; Wootton J.C.; Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990,4(7),1207-1214","journal-title":"Mol Microbiol"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1128\/AAC.46.6.1845-1850.2002","volume":"46","author":"Singh K. V.","year":"2002","unstructured":"Singh K. V.; Weinstock G.M.; Murray B.E.; An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 2002,46(6),1845-1850","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj20020957","volume":"376","author":"Borges-Walmsley M.I.","year":"2003","unstructured":"Borges-Walmsley M.I.; McKEEGAN KS, Walmsley AR. Structure and function of efflux pumps that confer resistance to drugs. Biochem J 2003,376(2),313-338","journal-title":"Biochem J"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1128\/JB.182.23.6694-6697.2000","volume":"182","author":"Morita Y.","year":"2000","unstructured":"Morita Y.; Kataoka A.; Shiota S.; Mizushima T.; Tsuchiya T.; NorM of vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump. J Bacteriol 2000,182(23),6694-6697","journal-title":"J Bacteriol"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1128\/JB.185.3.1101-1106.2003","volume":"185","author":"Rouquette-Loughlin C.","year":"2003","unstructured":"Rouquette-Loughlin C.; Dunham S.A.; Kuhn M.; Balthazar J.T.; Shafer W.M.; The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol 2003,185(3),1101-1106","journal-title":"J Bacteriol"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jac\/dkg126","volume":"51","author":"Yang S.","year":"2003","unstructured":"Yang S.; Clayton S.R.; Zechiedrich E.L.; Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 2003,51(3),545-556","journal-title":"J Antimicrob Chemother"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","volume":"62","author":"Pao S.S.","year":"1998","unstructured":"Pao S.S.; Paulsen I.T.; Saier M.H.; Major facilitator superfamily. Microbiol Mol Biol Rev 1998,62(1),1-34","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1742-4658.2012.08588.x","volume":"279","author":"Reddy V.S.","year":"2012","unstructured":"Reddy V.S.; Shlykov M.A.; Castillo R.; Sun E.I.; Saier M.H.; The major facilitator superfamily (MFS) revisited. FEBS J 2012,279(11),2022-2035","journal-title":"FEBS J"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/pro.5560040319","volume":"4","author":"Goswitz V.C.","year":"1995","unstructured":"Goswitz V.C.; Brooker R.J.; Structural features of the uniporter\/symporter\/antiporter superfamily. Protein Sci 1995,4(3),534-537","journal-title":"Protein Sci"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","volume":"19","author":"Piddock L.J.V.","year":"2006","unstructured":"Piddock L.J.V.; Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006,19(2),382-402","journal-title":"Clin Microbiol Rev"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1128\/jb.172.12.6942-6949.1990","volume":"172","author":"Yoshida H.","year":"1990","unstructured":"Yoshida H.; Bogaki M.; Nakamura S.; Ubukata K.; Konno M.; Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 1990,172(12),6942-6949","journal-title":"J Bacteriol"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0968-0004(93)90081-w","volume":"18","author":"Marger M.D.","year":"1993","unstructured":"Marger M.D.; Saier M.H.; A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci 1993,18(1),13-20","journal-title":"Trends Biochem Sci"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0959-440X(05)80082-X","volume":"1","author":"Henderson P.J.F.","year":"1991","unstructured":"Henderson P.J.F.; Sugar transport proteins. Curr Opin Struct Biol 1991,1(4),590-601","journal-title":"Curr Opin Struct Biol"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13205-018-1476-8","volume":"8","author":"Vishwakarma P","year":"2018","unstructured":"Vishwakarma P; Banerjee A; Pasrija R; Prasad R; Lynn AM; Phylogenetic and conservation analyses of MFS transporters. 3 Biotech 2018,8(11),462","journal-title":"3 Biotech"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/scdb.2000.0246","volume":"12","author":"Saier M.H.","year":"2001","unstructured":"Saier M.H.; Paulsen I.T.; Phylogeny of multidrug transporters. Semin Cell Dev Biol 2001,12(3),205-213","journal-title":"Semin Cell Dev Biol"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1073\/pnas.93.8.3630","volume":"938","author":"Paulsen I.T.","year":"1996","unstructured":"Paulsen I.T.; Brown M.H.; Littlejohn T.G.; Mitchell B.A.; Skurray R.A.; Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci USA 1996,938,3630-3635","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=307","first-page":"1","volume":"135","author":"Tennent J.M.","year":"1989","unstructured":"Tennent J.M.; Lyon B.R.; Midgley M.; Jones I.G.; Purewal A.S.; Skurray R.A.; Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 1989,135(1),1-10","journal-title":"J Gen Microbiol"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-2958.1996.01521.x","volume":"22","author":"Clancy J.","year":"1996","unstructured":"Clancy J.; Petitpas J.; Dib-Hajj F.; Molecular cloning and functional analysis of a novel macrolide\u2010resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 1996,22(5),867-879","journal-title":"Mol Microbiol"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"Chopra I.","year":"2001","unstructured":"Chopra I.; Roberts M.; Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001,65(2),232-260","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.addr.2005.04.004","volume":"57","author":"Kumar A.","year":"2005","unstructured":"Kumar A.; Schweizer H.; Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv Drug Deliv Rev 2005,57(10),1486-1513","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jmb.2008.01.056","volume":"377","author":"Korkhov V.M.","year":"2008","unstructured":"Korkhov V.M.; Tate C.G.; Electron crystallography reveals plasticity within the drug binding site of the small multidrug transporter EmrE. J Mol Biol 2008,377(4),1094-1103","journal-title":"J Mol Biol"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1073\/pnas.0400137101","volume":"101","author":"Ma C.","year":"2004","unstructured":"Ma C.; Chang G.; Structure of the multidrug efflux transporter emre from Escherichia coli. Proc Natl Acad Sci USA 2004,101(9),2852-2857","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1365-2958.1996.tb02462.x","volume":"19","author":"Paulsen I.T.","year":"1996","unstructured":"Paulsen I.T.; Skurray R.A.; Tam R.; The SMR family: A novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol Microbiol 1996,19(6),1167-1175","journal-title":"Mol Microbiol"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bbamem.2007.08.015","volume":"1778","author":"Bay D.C.","year":"2008","unstructured":"Bay D.C.; Rommens K.L.; Turner R.J.; Small multidrug resistance proteins: A multidrug transporter family that continues to grow. Biochim Biophys Acta Biomembr 2008,1778(9),1814-1838","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/MMBR.64.4.672-693.2000","volume":"64","author":"Putman M.","year":"2000","unstructured":"Putman M.; van Veen H.W.; Konings W.N.; Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 2000,64(4),672-693","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0147-619X(92)90012-Y","volume":"27","author":"Grinius L.","year":"1992","unstructured":"Grinius L.; Dreguniene G.; Goldberg E.B.; Liao C.H.; Projan S.J.; A staphylococcal multidrug resistance gene product is a member of a new protein family. Plasmid 1992,27(2),119-129","journal-title":"Plasmid"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1242\/jeb.200.2.335","volume":"200","author":"Schuldiner S.","year":"1997","unstructured":"Schuldiner S.; Lebendiker M.; Yerushalmi H.; EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies. J Exp Biol 1997,200(2),335-341","journal-title":"J Exp Biol"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2148-9-140","volume":"9","author":"Bay D.C.","year":"2009","unstructured":"Bay D.C.; Turner R.J.; Diversity and evolution of the small multidrug resistance protein family. BMC Evol Biol 2009,9(1),140","journal-title":"BMC Evol Biol"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1128\/AAC.48.9.3332-3337.2004","volume":"48","author":"Hansen L.H.","year":"2004","unstructured":"Hansen L.H.; Johannesen E.; Burm&#xF8;lle M.; S&#xF8;rensen A.H.; S&#xF8;rensen S.J.; Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 2004,48(9),3332-3337","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/07853890701195262","volume":"39","author":"Poole K.","year":"2007","unstructured":"Poole K.; Efflux pumps as antimicrobial resistance mechanisms. Ann Med 2007,39(3),162-176","journal-title":"Ann Med"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbapap.2008.10.010","volume":"1794","author":"Zgurskaya H.I.","year":"2009","unstructured":"Zgurskaya H.I.; Yamada Y.; Tikhonova E.B.; Ge Q.; Krishnamoorthy G.; Structural and functional diversity of bacterial membrane fusion proteins. Biochim Biophys Acta Proteins Proteomics 2009,1794(5),794-807","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=322","first-page":"255","volume":"3","author":"Poole K.","year":"2001","unstructured":"Poole K.; Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 2001,3(2),255-264","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1128\/jb.175.19.6299-6313.1993","volume":"175","author":"Ma D.","year":"1993","unstructured":"Ma D.; Cook D.N.; Alberti M.; Pon N.G.; Nikaido H.; Hearst J.E.; Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 1993,175(19),6299-6313","journal-title":"J Bacteriol"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2958.1995.tb02390.x","volume":"16","author":"Ma D.","year":"1995","unstructured":"Ma D.; Cook D.N.; Alberti M.; Pon N.G.; Nikaido H.; Hearst J.E.; Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 1995,16(1),45-55","journal-title":"Mol Microbiol"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature01050","volume":"419","author":"Murakami S.","year":"2002","unstructured":"Murakami S.; Nakashima R.; Yamashita E.; Yamaguchi A.; Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 2002,419(6907),587-593","journal-title":"Nature"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jmb.2009.04.001","volume":"389","author":"Sennhauser G.","year":"2009","unstructured":"Sennhauser G.; Bukowska M.A.; Briand C.; Gr&#xFC;tter M.G.; Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J Mol Biol 2009,389(1),134-145","journal-title":"J Mol Biol"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"10517","DOI":"10.1074\/jbc.274.15.10517","volume":"274","author":"Guan L.","year":"1999","unstructured":"Guan L.; Ehrmann M.; Yoneyama H.; Nakae T.; Membrane topology of the xenobiotic-exporting subunit, MexB, of the MexA,B-OprM extrusion pump in Pseudomonas aeruginosa. J Biol Chem 1999,274(15),10517-10522","journal-title":"J Biol Chem"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1128\/AAC.39.9.1948","volume":"39","author":"Li X.Z.","year":"1995","unstructured":"Li X.Z.; Nikaido H.; Poole K.; Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995,39(9),1948-1953","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1751-7915.2010.00189.x","volume":"3","author":"Godoy P.","year":"2010","unstructured":"Godoy P.; Molina-Henares A.J.; De La Torre J.; Duque E.; Ramos J.L.; Characterization of the RND family of multidrug efflux pumps: In silico to in vivo confirmation of four functionally distinct subgroups. Microb Biotechnol 2010. Microb Biotechnol 2010,3(6),691-700","journal-title":"Microb Biotechnol"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1073\/pnas.1525143113","volume":"113","author":"Kinana A.D.","year":"2016","unstructured":"Kinana A.D.; Vargiu A. V.; May T.; Nikaido H.; Aminoacyl &#x3B2;-Naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad Sci USA 2016,113(5),1405-0","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/mdr.2004.10.197","volume":"10","author":"Noguchi N.","year":"2004","unstructured":"Noguchi N.; Okada H.; Narui K.; Sasatsu M.; Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb Drug Resist 2004,10(3),197-203","journal-title":"Microb Drug Resist"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jac\/42.4.561","volume":"42","author":"Schmitz F.J.","year":"1998","unstructured":"Schmitz F.J.; Hertel B.; Hofmann B.; Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J Antimicrob Chemother 1998,42(4),561-563","journal-title":"J Antimicrob Chemother"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jac\/46.1.145","volume":"46","author":"Sierra J.M.","year":"2000","unstructured":"Sierra J.M.; Ruiz J.; Vila J.; Vila J.; Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus. J Antimicrob Chemother 2000,46(1),145-146","journal-title":"J Antimicrob Chemother"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1128\/AAC.37.1.128","volume":"37","author":"Neyfakh A.A.","year":"1993","unstructured":"Neyfakh A.A.; Borsch C.M.; Kaatz G.W.; Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux trans-porter. Antimicrob Agents Chemother 1993,37(1),128-129","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1128\/AAC.37.5.1086","volume":"37","author":"Kaatz G.W.","year":"1993","unstructured":"Kaatz G.W.; Seo S.M.; Ruble C.A.; Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993,37(5),1086-1094","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1128\/AAC.38.6.1345","volume":"38","author":"Ng E.Y.","year":"1994","unstructured":"Ng E.Y.; Trucksis M.; Hooper D.C.; Quinolone resistance mediated by norA: Physiologic characterization and relationship to flqB, a quino-lone resistance locus on the Staphylococcus aureus chromosome. Antimicrob Agents Chemother 1994,38(6),1345-1355","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1128\/AAC.44.9.2233-2241.2000","volume":"44","author":"Poole K.","year":"2000","unstructured":"Poole K.; Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 2000,44(9),2233-2241","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.3390\/ijms20164041","volume":"20","author":"Palazzotti D.","year":"2019","unstructured":"Palazzotti D.; Bissaro M.; Bolcato G.; Deciphering the molecular recognition mechanism of multidrug resistance Staphylococcus aureus NorA efflux pump using a supervised molecular dynamics approach. Int J Mol Sci 2019,20(16),4041","journal-title":"Int J Mol Sci"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2217\/fmb.13.16","volume":"8","author":"Schindler B.D.","year":"2013","unstructured":"Schindler B.D.; Jacinto P.; Kaatz G.W.; Inhibition of drug efflux pumps in Staphylococcus aureus: Current status of potentiating existing antibiotics. Future Microbiol 2013,8(4),491-507","journal-title":"Future Microbiol"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1128\/AAC.42.8.2119","volume":"42","author":"Miyamae S.","year":"1998","unstructured":"Miyamae S.; Nikaido H.; Tanaka Y.; Yoshimura F.; Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob Agents Chemother 1998,42(8),2119-2121","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/infdis\/163.5.1080","volume":"163","author":"Kaatz G.W.","year":"1991","unstructured":"Kaatz G.W.; Seo S.M.; Ruble C.A.; Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis 1991,163(5),1080-1086","journal-title":"J Infect Dis"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/jac\/dkn217","volume":"62","author":"Couto I.","year":"2008","unstructured":"Couto I.; Costa S.S.; Viveiros M.; Martins M.; Amaral L.; Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemother 2008,62(3),504-513","journal-title":"J Antimicrob Chemother"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/jac\/dkh341","volume":"54","author":"Kaatz G.W.","year":"2004","unstructured":"Kaatz G.W.; Seo S.M.; Effect of substrate exposure and other growth condition manipulations on norA expression. J Antimicrob Chemother 2004,54(2),364-369","journal-title":"J Antimicrob Chemother"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/JB.183.7.2367-2371.2001","volume":"183","author":"Fournier B.","year":"2001","unstructured":"Fournier B.; Truong-Bolduc Q.C.; Zhang X.; Hooper D.C.; A mutation in the 5\u2032 untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J Bacteriol 2001,183(7),2367-2371","journal-title":"J Bacteriol"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1128\/AAC.00430-07","volume":"51","author":"DeMarco C.E.","year":"2007","unstructured":"DeMarco C.E.; Cushing L.A.; Frempong-Manso E.; Seo S.M.; Jaravaza T.A.A.; Kaatz G.W.; Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2007,51(9),3235-3239","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1099\/mic.0.2008\/021188-0","volume":"154","author":"Huet A.A.","year":"2008","unstructured":"Huet A.A.; Raygada J.L.; Mendiratta K.; Seo S.M.; Kaatz G.W.; Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes. Microbiology 2008,154(10),3144-3153","journal-title":"Microbiology"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1126\/science.6243420","volume":"207","author":"Cozzarelli NR","year":"1980","unstructured":"Cozzarelli NR; DNA gyrase and the supercoiling of DNA. Science 1980,207(4434),953-60","journal-title":"Science"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1054\/drup.1998.0068","volume":"2","author":"Hooper D.C.","year":"1999","unstructured":"Hooper D.C.; Mechanisms of fluoroquinolone resistance. Drug Resist Updat 1999,2(1),38-55","journal-title":"Drug Resist Updat"},{"key":"ref=349","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/jac\/dkf047","volume":"49","author":"Smith H.J.","year":"2002","unstructured":"Smith H.J.; Nichol K.A.; Hoban D.J.; Zhanel G.G.; Dual activity of fluoroquinolones against Streptococcus Pneumoniae: The facts behind the claims. J Antimicrob Chemother 2002,49(6),893-895","journal-title":"J Antimicrob Chemother"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/antibiotics7020032","volume":"7","author":"Gutierrez A.","year":"2018","unstructured":"Gutierrez A.; Stokes J.; Matic I.; Our evolving understanding of the mechanism of quinolones. Antibiotics 2018,7(2),32","journal-title":"Antibiotics"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","volume":"65","author":"Wang J.C.","year":"1996","unstructured":"Wang J.C.; DNA topoisomerases. Annu Rev Biochem 1996,65(1),635-692","journal-title":"Annu Rev Biochem"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"1800141","DOI":"10.1002\/ardp.201800141","volume":"351","author":"Ezelarab H.A.A.","year":"2018","unstructured":"Ezelarab H.A.A.; Abbas S.H.; Hassan H.A.; Abuo-Rahma G.E.D.A.; Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm 2018,351(9),1800141","journal-title":"Arch Pharm"},{"key":"ref=353","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.22.2859","author":"Zechiedrich E.L.","year":"1995","unstructured":"Zechiedrich E.L.; Cozzarelli N.R.; Roles of topoisomerase IV and during replication in Eschericia coli. Genes Dev 1995","journal-title":"Genes Dev"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.1074\/jbc.272.14.9401","volume":"272","author":"Marians K.J.","year":"1997","unstructured":"Marians K.J.; Hiasa H.; Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV. J Biol Chem 1997,272(14),9401-9409","journal-title":"J Biol Chem"},{"key":"ref=355","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0149-2918(00)88266-1","volume":"21","author":"Blandeau J.M.","year":"1999","unstructured":"Blandeau J.M.; Expanded activity and utility of the new fluoroquinolones: A review. Clin Ther 1999,21(1),3-40","journal-title":"Clin Ther"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jac\/41.4.481","volume":"41","author":"Schmitz F.","year":"1998","unstructured":"Schmitz F.; Hofmann B.; Hansen B.; Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1998,41(4),481-484","journal-title":"J Antimicrob Chemother"},{"key":"ref=357","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/dkg059","volume":"51","author":"Fisher L.M.","year":"2003","unstructured":"Fisher L.M.; Heaton V.J.; Dual activity of fluoroquinolones against Streptococcus Pneumoniae. J Antimicrob Chemother 2003,51(2),463-464","journal-title":"J Antimicrob Chemother"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jac\/29.3.245","volume":"29","author":"Chopra I.","year":"1992","unstructured":"Chopra I.; Hawkey P.M.; Hinton M.; Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 1992,29(3),245-277","journal-title":"J Antimicrob Chemother"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/CMR.5.4.387","volume":"5","author":"Speer B.S.","year":"1992","unstructured":"Speer B.S.; Shoemaker N.B.; Salyers A.A.; Bacterial resistance to tetracycline: Mechanisms, transfer, and clinical significance. Clin Microbiol Rev 1992,5(4),387-399","journal-title":"Clin Microbiol Rev"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6976.1996.tb00251.x","volume":"19","author":"Roberts M.C.","year":"1996","unstructured":"Roberts M.C.; Tetracycline resistance determinants: Mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev 1996,19(1),1-24","journal-title":"FEMS Microbiol Rev"},{"key":"ref=361","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0960-894X(99)00216-4","volume":"9","author":"Sum P.E.","year":"1999","unstructured":"Sum P.E.; Petersen P.; Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorganic Med Chem Lett 1999,9(10),1459-1462","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1128\/AAC.37.11.2270","volume":"37","author":"Testa R.T.","year":"1993","unstructured":"Testa R.T.; Petersen P.J.; Jacobus N.V.; Sum P.E.; Lee V.J.; Tally F.P.; In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother 1993,37(11),2270-2277","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=363","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1574-6968.1987.tb02117.x","volume":"43","author":"Gillespie M.T.","year":"1987","unstructured":"Gillespie M.T.; Lyon B.R.; Loo L.S.L.; Matthews P.R.; Stewart P.R.; Skurray R.A.; Homologous direct repeat sequences associated with mercury, methicillin, tetracycline and trimethoprim resistance determinants in Staphylococcus aureus. FEMS Microbiol Lett 1987,43(2),165-171","journal-title":"FEMS Microbiol Lett"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1099\/00221287-140-10-2577","volume":"140","author":"Needham C.","year":"1994","unstructured":"Needham C.; Rahman M.; Dyke K.G.H.; Noble W.C.; An investigation of plasmids from Staphylococcus aureus that mediate resistance to mupirocin and tetracycline. Microbiology 1994,140(10),2577-2583","journal-title":"Microbiology"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0378-1135(98)00234-X","volume":"63","author":"Schwarz S.","year":"1998","unstructured":"Schwarz S.; Roberts M.C.; Werckenthin C.; Pang Y.; Lange C.; Tetracycline resistance in Staphylococcus spp. from domestic animals. Vet Microbiol 1998,63(2-4),217-227","journal-title":"Vet Microbiol"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0147-619X(88)90039-X","volume":"19","author":"Projan S.J.","year":"1988","unstructured":"Projan S.J.; Novick R.; Comparative analysis of five related staphylococcal plasmids. Plasmid 1988,19(3),203-221","journal-title":"Plasmid"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0147-619X(83)90039-2","volume":"10","author":"Khan S.A.","year":"1983","unstructured":"Khan S.A.; Novick R.P.; Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 1983,10(3),251-259","journal-title":"Plasmid"},{"key":"ref=368","author":"McMurry L.M.","year":"2000","unstructured":"McMurry L.M.; Levy S.; Tetracycline Resistance in Gram-Positive Bacteria. Gram-Positive Pathogens; 2000","journal-title":"Gram-Positive Pathogens;"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","volume":"103","author":"Brodersen D.E.","year":"2000","unstructured":"Brodersen D.E.; Clemons W.M.; Carter A.P.; Morgan-Warren R.J.; Wimberly B.T.; Ramakrishnan V.; The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 2000,103(7),1143-1154","journal-title":"Cell"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1128\/jb.179.11.3786-3789.1997","volume":"179","author":"Ginn S.L.","year":"1997","unstructured":"Ginn S.L.; Brown M.H.; Skurray R.A.; Membrane topology of the metal-tetracycline\/H+ antiporter TetA(K) from Staphylococcus aureus. J Bacteriol 1997,179(11),3786-3789","journal-title":"J Bacteriol"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1016\/S0021-9258(19)34044-X","volume":"265","author":"Yamaguchi A.","year":"1990","unstructured":"Yamaguchi A.; Udagawa T.; Sawai T.; Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein. J Biol Chem 1990,265(9),4809-4813","journal-title":"J Biol Chem"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"20330","DOI":"10.1074\/jbc.M007993200","volume":"276","author":"Tamura N.","year":"2001","unstructured":"Tamura N.; Konishi S.; Iwaki S.; Kimura-Someya T.; Nada S.; Yamaguchi A.; Complete cysteine-scanning mutagenesis and site-directed chemical modification of the Tn10-encoded metaltetracycline\/H+ antiporter. J Biol Chem 2001,276(23),20330-20339","journal-title":"J Biol Chem"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","volume":"49","author":"McAleese F.","year":"2005","unstructured":"McAleese F.; Petersen P.; Ruzin A.; A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 2005,49(5),1865-1871","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=374","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/JB.186.1.262-265.2004","volume":"186","author":"He G.X.","year":"2004","unstructured":"He G.X.; Kuroda T.; Mima T.; Morita Y.; Mizushima T.; Tsuchiya T.; An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J Bacteriol 2004,186(1),262-265","journal-title":"J Bacteriol"},{"key":"ref=375","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1128\/AAC.50.4.1276-1281.2006","volume":"50","author":"Kaatz G.W.","year":"2006","unstructured":"Kaatz G.W.; DeMarco C.E.; Seo S.M.; MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein. Antimicrob Agents Chemother 2006,50(4),1276-1281","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/346362a0","volume":"346","author":"Hyde S.C.","year":"1990","unstructured":"Hyde S.C.; Emsley P.; Hartshorn M.J.; Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990,346(6282),362-365","journal-title":"Nature"},{"key":"ref=377","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0924-8579(03)00218-8","volume":"22","author":"Reynolds E.","year":"2003","unstructured":"Reynolds E.; Ross J.I.; Cove J.H.; Msr(A) and related macrolide\/streptogramin resistance determinants: incomplete transporters? Int J Antimicrob Agents 2003,22(3),228-236","journal-title":"Int J Antimicrob Agents"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1128\/AAC.49.8.3586-3589.2005","volume":"49","author":"Novotna G.","year":"2005","unstructured":"Novotna G.; Adamkova V.; Janata J.; Melter O.; Spizek J.; Prevalence of resistance mechanisms against macrolides and lincosamides in methicillin-resistant coagulase-negative staphylococci in the Czech Republic and occurrence of an undefined mechanism of resistance to lincosamides. Antimicrob Agents Chemother 2005,49(8),3586-3589","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=379","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/jac\/24.6.851","volume":"24","author":"Ross J.I.","year":"1989","unstructured":"Ross J.I.; Farrell A.M.; Eady E.A.; Cove J.H.; Cunliffe W.J.; Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother 1989,24(6),851-862","journal-title":"J Antimicrob Chemother"},{"key":"ref=380","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2004.01.044","volume":"315","author":"Kerr I.D.","year":"2004","unstructured":"Kerr I.D.; Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition. Biochem Biophys Res Commun 2004,315(1),166-173","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1128\/AAC.34.9.1787","volume":"34","author":"Capobianco J.O.","year":"1990","unstructured":"Capobianco J.O.; Goldman R.C.; Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta &#x3BC; H). Antimicrob Agents Chemother 1990,34(9),1787-1791","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1042\/BST20051000","volume":"33","author":"Kerr I.D.","year":"2005","unstructured":"Kerr I.D.; Reynolds E.D.; Cove J.H.; ABC proteins and antibiotic drug resistance: Is it all about transport? Biochem Soc Trans 2005,33(Pt 5),1000-1002","journal-title":"Biochem Soc Trans"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/mas.20189","volume":"28","author":"Wang J.","year":"2009","unstructured":"Wang J.; Analysis of macrolide antibiotics, using liquid chromatography-mass spectrometry, in food, biological and environmental matri-ces. Mass Spectrom Rev 2009,28(1),50-92","journal-title":"Mass Spectrom Rev"},{"key":"ref=384","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"Kanoh S.","year":"2010","unstructured":"Kanoh S.; Rubin B.K.; Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010,23(3),590-615","journal-title":"Clin Microbiol Rev"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","volume":"330","author":"Tenson T.","year":"2003","unstructured":"Tenson T.; Lovmar M.; Ehrenberg M.; The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol 2003,330(5),1005-1014","journal-title":"J Mol Biol"},{"key":"ref=386","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/35101544","volume":"413","author":"Schl&#xFC;nzen F.","year":"2001","unstructured":"Schl&#xFC;nzen F.; Zarivach R.; Harms J.; Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001,413(6858),814-821","journal-title":"Nature"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.chemosphere.2015.03.085","volume":"136","author":"Guo M.T.","year":"2015","unstructured":"Guo M.T.; Yuan Q.B.; Yang J.; Insights into the amplification of bacterial resistance to erythromycin in activated sludge. Chemosphere 2015,136,79-85","journal-title":"Chemosphere"},{"key":"ref=388","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/AAC.00781-08","volume":"53","author":"Varaldo P.E.","year":"2009","unstructured":"Varaldo P.E.; Montanari M.P.; Giovanetti E.; Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009,53(2),343-353","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=389","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2174\/15680266113136660223","volume":"13","author":"Liang J.H.","year":"2013","unstructured":"Liang J.H.; Han X.; Structure-activity relationships and mechanism of action of macrolides derived from erythromycin as antibacterial agents. Curr Top Med Chem 2013,13(24),3131-3164","journal-title":"Curr Top Med Chem"},{"key":"ref=390","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157489112799829710","volume":"7","author":"Ashima K.B.","year":"2012","unstructured":"Ashima K.B.; Mohanty P.; Bacterial efflux pumps involved in multidrug resistance and their inhibitors: Rejuvinating the antimicrobial chemotherapy. Recent Pat Antiinfect Drug Discov 2012,7(1),73-89","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=391","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00003495-200464020-00004","volume":"64","author":"Li X.Z.","year":"2004","unstructured":"Li X.Z.; Nikaido H.; Efflux-mediated drug resistance in bacteria. Drugs 2004,64(2),159-204","journal-title":"Drugs"},{"key":"ref=392","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/157489109787236256","volume":"4","author":"Zechini B.","year":"2009","unstructured":"Zechini B.; Versace I.; Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov 2009,4(1),37-50","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=393","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dkg269","volume":"52","author":"Drlica K.","year":"2003","unstructured":"Drlica K.; The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 2003,52(1),11-17","journal-title":"J Antimicrob Chemother"},{"key":"ref=394","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1099\/mic.0.069286-0","volume":"159","author":"Purssell A.","year":"2013","unstructured":"Purssell A.; Poole K.; Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa. Microbiology (Reading) 2013,159(Pt 10),2058-2073","journal-title":"Microbiology (Reading)"},{"key":"ref=395","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1271\/bbb.100433","volume":"74","author":"Zeng B.","year":"2010","unstructured":"Zeng B.; Wang H.; Zou L.; Zhang A.; Yang X.; Guan Z.; Evaluation and target validation of indole derivatives as inhibitors of the AcrAB-TolC efflux pump. Biosci Biotechnol Biochem 2010,74(11),2237-2241","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=396","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","volume":"31","author":"Martins M.","year":"2008","unstructured":"Martins M.; Dastidar S.G.; Fanning S.; Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant gram-negative infections: Mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008,31(3),198-208","journal-title":"Int J Antimicrob Agents"},{"key":"ref=397","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/AAC.49.8.3578-3582.2005","volume":"49","author":"Viveiros M.","year":"2005","unstructured":"Viveiros M.; Jesus A.; Brito M.; Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of pro-ton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 2005,49(8),3578-3582","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=398","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.molmed.2005.06.006","volume":"11","author":"Pag&#xE8;s J.M.","year":"2005","unstructured":"Pag&#xE8;s J.M.; Masi M.; Barbe J.; Inhibitors of efflux pumps in gram-negative bacteria. Trends Mol Med 2005,11(8),382-389","journal-title":"Trends Mol Med"},{"key":"ref=399","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157489106777452692","volume":"1","author":"Van Bambeke F.","year":"2006","unstructured":"Van Bambeke F.; Pag&#xE8;s J-M.; Lee V.J.; Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov 2006,1(2),157-175","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=400","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chembiol.2011.02.011","volume":"18","author":"Tikhonova E.B.","year":"2011","unstructured":"Tikhonova E.B.; Yamada Y.; Zgurskaya H.I.; Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Chem Biol 2011,18(4),454-463","journal-title":"Chem Biol"},{"key":"ref=401","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1128\/AAC.48.9.3621-3624.2004","volume":"48","author":"Chollet R.","year":"2004","unstructured":"Chollet R.; Chevalier J.; Bryskier A.; Pag&#xE8;s J.M.; The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother 2004,48(9),3621-3624","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=402","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/jm040114b","volume":"48","author":"Rice A.","year":"2005","unstructured":"Rice A.; Liu Y.; Michaelis M.L.; Himes R.H.; Georg G.I.; Audus K.L.; Chemical modification of paclitaxel (Taxol) reduces p-glycoprotein interactions and increases permeation across the blood\u2212brain barrier in vitro and in situ. J Med Chem 2005,48(3),832-838","journal-title":"J Med Chem"},{"key":"ref=403","doi-asserted-by":"publisher","first-page":"16696","DOI":"10.1073\/pnas.1210093109","volume":"109","author":"Hobbs E.C.","year":"2012","unstructured":"Hobbs E.C.; Yin X.; Paul B.J.; Astarita J.L.; Storz G.; Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance. Proc Natl Acad Sci USA 2012,109(41),16696-16701","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=404","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1368-7646(02)00051-1","volume":"5","author":"Chopra I.","year":"2002","unstructured":"Chopra I.; New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors. Drug Resist Updat 2002,5(3-4),119-125","journal-title":"Drug Resist Updat"},{"key":"ref=405","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bmcl.2003.12.015","volume":"14","author":"Zloh M.","year":"2004","unstructured":"Zloh M.; Kaatz G.W.; Gibbons S.; Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. Bioorganic Med Chem Lett 2004,14(4),881-885","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=406","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12300","volume":"500","author":"Nakashima R.","year":"2013","unstructured":"Nakashima R.; Sakurai K.; Yamasaki S.; Structural basis for the inhibition of bacterial multidrug exporters. Nature 2013,500(7460),102-106","journal-title":"Nature"},{"key":"ref=407","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1128\/AAC.01866-13","volume":"58","author":"Opperman T.J.","year":"2014","unstructured":"Opperman T.J.; Kwasny S.M.; Kim H.S.; Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob Agents Chemother 2014,58(2),722-733","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=408","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.bmc.2015.03.016","volume":"23","author":"Nguyen S.T.","year":"2015","unstructured":"Nguyen S.T.; Kwasny S.M.; Ding X.; Structure-activity relationships of a novel pyranopyridine series of gram-negative bacterial efflux pump inhibitors. Bioorganic Med Chem 2015,23(9),2024-2034","journal-title":"Bioorganic Med Chem"},{"key":"ref=409","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fmicb.2015.00421","volume":"6","author":"Opperman T.J.","year":"2015","unstructured":"Opperman T.J.; Nguyen S.T.; Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol 2015,6,421","journal-title":"Front Microbiol"},{"key":"ref=410","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.2174\/092986711796150469","volume":"18","author":"Pag&#xE8;s J.M.","year":"2011","unstructured":"Pag&#xE8;s J.M.; Amaral L.; Fanning S.; An original deal for new molecule: Reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. Curr Med Chem 2011,18(19),2969-2980","journal-title":"Curr Med Chem"},{"key":"ref=411","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.biochi.2005.04.012","volume":"87","author":"Marquez B.","year":"2005","unstructured":"Marquez B.; Bacterial efflux systems and efflux pumps inhibitors. Biochimie 2005,87(12),1137-1147","journal-title":"Biochimie"},{"key":"ref=412","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1128\/AAC.01053-10","volume":"55","author":"Spindler E.C.","year":"2011","unstructured":"Spindler E.C.; Hale J.D.F.; Giddings T.H.; Hancock R.E.W.; Gill R.T.; Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob Agents Chemother 2011,55(4),1706-1716","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=413","doi-asserted-by":"publisher","first-page":"e0135198","DOI":"10.1371\/journal.pone.0135198","volume":"10","author":"Yu Z.","year":"2015","unstructured":"Yu Z.; Cai Y.; Qin W.; Lin J.; Qiu J.; Polymyxin E induces rapid Paenibacillus polymyxa death by damaging cell membrane while Ca can protect cells from damage. PLoS One 2015,10(8),e0135198","journal-title":"PLoS One"},{"key":"ref=414","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1128\/AAC.00248-16","volume":"60","author":"Ni W.","year":"2016","unstructured":"Ni W.; Li Y.; Guan J.; Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria. Antimicrob Agents Chemother 2016,60(5),3215-3218","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=415","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12275-015-4498-5","volume":"53","author":"Park Y.K.","year":"2015","unstructured":"Park Y.K.; Ko K.S.; Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin. J Microbiol 2015,53(1),53-59","journal-title":"J Microbiol"},{"key":"ref=416","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bjm.2016.01.007","volume":"47","author":"Mohamed Y.F.","year":"2016","unstructured":"Mohamed Y.F.; Abou-Shleib H.M.; Khalil A.M.; El-Guink N.M.; El-Nakeeb M.A.; Membrane permeabilization of colistin toward pandrug resistant gram-negative isolates. Braz J Microbiol 2016,47(2),381-388","journal-title":"Braz J Microbiol"},{"key":"ref=417","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1099\/jmm.0.010876-0","volume":"58","author":"Anoushiravani M.","year":"2009","unstructured":"Anoushiravani M.; Falsafi T.; Niknam V.; Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori. J Med Microbiol 2009,58(10),1309-1313","journal-title":"J Med Microbiol"},{"key":"ref=418","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jac\/dkp027","volume":"63","author":"Fenosa A.","year":"2009","unstructured":"Fenosa A.; Fust&#xE9; E.; Ruiz L.; Role of TolC in Klebsiella oxytoca resistance to antibiotics. J Antimicrob Chemother 2009,63(4),668-674","journal-title":"J Antimicrob Chemother"},{"key":"ref=419","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fmicb.2017.00228","volume":"8","author":"Osei Sekyere J.","year":"2017","unstructured":"Osei Sekyere J.; Amoako D.G.; Carbonyl cyanide mchlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae. Front Microbiol 2017,8,228","journal-title":"Front Microbiol"},{"key":"ref=420","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"Li X.Z.","year":"2015","unstructured":"Li X.Z.; Pl&#xE9;siat P.; Nikaido H.; The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clin Microbiol Rev 2015,28(2),337-418","journal-title":"Clin Microbiol Rev"},{"key":"ref=421","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.diagmicrobio.2008.06.008","volume":"62","author":"Huang L.","year":"2008","unstructured":"Huang L.; Sun L.; Xu G.; Xia T.; Differential susceptibility to carbapenems Due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese Hospital. Diagn Microbiol Infect Dis 2008,62(3),326","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=422","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","volume":"45","author":"Lomovskaya O.","year":"2001","unstructured":"Lomovskaya O.; Warren M.S.; Lee A.; Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseu-domonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother 2001,45(1),105-116","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=423","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2174\/138945006777709557","volume":"7","author":"Mahamoud A.","year":"2006","unstructured":"Mahamoud A.; Chevalier J.; Davin-Regli A.; Barbe J.; Pag&#xE8;s J.M.; Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. Curr Drug Targets 2006,7(7),843-847","journal-title":"Curr Drug Targets"},{"key":"ref=424","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/jac\/dkg181","volume":"51","author":"S&#xE1;nchez P.","year":"2003","unstructured":"S&#xE1;nchez P.; Le U.; Mart&#xED;nez J.L.; The efflux pump inhibitor Phe-Arg-&#x3B2;-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump. J Antimicrob Chemother 2003,51(4),1042-1045","journal-title":"J Antimicrob Chemother"},{"key":"ref=425","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2174\/0929867323666160304150522","volume":"23","author":"Mahmood Y.","year":"2016","unstructured":"Mahmood Y.; Current advances in developing inhibitors of bacterial multidrug efflux pumps. Curr Med Chem 2016 2016,23(10),1062-1081","journal-title":"Curr Med Chem 2016"},{"key":"ref=426","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fmicb.2015.00660","volume":"6","author":"Dreier J.","year":"2015","unstructured":"Dreier J.; Ruggerone P.; Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol 2015,6,660","journal-title":"Front Microbiol"},{"key":"ref=427","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1021\/jm9904598","volume":"42","author":"Renau T.E.","year":"1999","unstructured":"Renau T.E.; L&#xE9;ger R.; Flamme E.M.; Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 1999,42(24),4928-4931","journal-title":"J Med Chem"},{"key":"ref=428","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.3402\/ljm.v6i0.5870","volume":"6","author":"Askoura M.","year":"2011","unstructured":"Askoura M.; Mattawa W.; Abujamel T.; Taher I.; Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J Med 2011,6(1),5870","journal-title":"Libyan J Med"},{"key":"ref=429","first-page":"225","volume":"3","author":"Lomovskaya O.","year":"2001","unstructured":"Lomovskaya O.; Watkins W.; Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 2001,3(2),225-236","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref=430","doi-asserted-by":"publisher","first-page":"e18547","DOI":"10.1371\/journal.pone.0018547","volume":"6","author":"Matsumoto Y.","year":"2011","unstructured":"Matsumoto Y.; Hayama K.; Sakakihara S.; Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS One 2011,6(4),e18547","journal-title":"PLoS One"},{"key":"ref=431","doi-asserted-by":"publisher","first-page":"e60666","DOI":"10.1371\/journal.pone.0060666","volume":"8","author":"Lamers R.P.","year":"2013","unstructured":"Lamers R.P.; Cavallari J.F.; Burrows L.L.; The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PA&#x3B2;N) permeabilizes the outer membrane of gram-negative bacteria. PLoS One 2013,8(3),e60666","journal-title":"PLoS One"},{"key":"ref=432","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bioorg.2017.08.004","volume":"74","author":"Tintino S.R.","year":"2017","unstructured":"Tintino S.R.; Morais-Tintino C.D.; Campina F.F.; Costa M.; Tannic acid affects the phenotype of Staphylococcus aureus resistant to tetracycline and erythromycin by inhibition of efflux pumps. Bioorg Chem 2017,74,197-200","journal-title":"Bioorg Chem"},{"key":"ref=433","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.micpath.2016.04.003","volume":"97","author":"Tintino S.R.","year":"2016","unstructured":"Tintino S.R.; Oliveira-Tintino C.D.M.; Campina F.F.; Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus. Microb Pathog 2016,97,9-13","journal-title":"Microb Pathog"},{"key":"ref=434","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.meegid.2020.104370","volume":"84","author":"Figueredo F.G.","year":"2020","unstructured":"Figueredo F.G.; Ramos I.T.L.; Paz J.A.; Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump. Infect Genet Evol 2020,84,104370","journal-title":"Infect Genet Evol"},{"key":"ref=435","doi-asserted-by":"publisher","first-page":"20637","DOI":"10.1073\/pnas.1218348109","volume":"109","author":"Vargiu A V","year":"2012","unstructured":"Vargiu A V; Nikaido H; Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci USA 2012 2012,109(50),20637-20642","journal-title":"Proc Natl Acad Sci USA 2012"},{"key":"ref=436","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1128\/AAC.03283-14","volume":"58","author":"Vargiu A.V.","year":"2014","unstructured":"Vargiu A.V.; Ruggerone P.; Opperman T.J.; Nguyen S.T.; Nikaido H.; Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob Agents Chemother 2014,58(10),6224-6234","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=437","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1016\/j.jmb.2017.09.018","volume":"429","author":"M&#xFC;ller R.T.","year":"2017","unstructured":"M&#xFC;ller R.T.; Travers T.; Cha H.; Phillips J.L.; Gnanakaran S.; Pos K.M.; Switch loop flexibility affects substrate transport of the acrb efflux pump. J Mol Biol 2017,429(24),3863-3874","journal-title":"J Mol Biol"},{"key":"ref=438","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/S0960-894X(03)00556-0","volume":"13","author":"Renau T.E.","year":"2003","unstructured":"Renau T.E.; L&#xE9;ger R.; Filonova L.; Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic Med Chem Lett 2003,13(16),2755-2758","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=439","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbapap.2008.12.011","volume":"1794","author":"Pag&#xE8;s J.M.","year":"2009","unstructured":"Pag&#xE8;s J.M.; Amaral L.; Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of gram-negative bacteria. Biochim Biophys Acta Proteins Proteomics 2009,1794(5),826-833","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=440","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1073\/pnas.1602472113","volume":"113","author":"Sjuts H.","year":"2016","unstructured":"Sjuts H.; Vargiu A. V.; Kwasny S.M.; Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc Natl Acad Sci USA 2016,113(13),3509-3514","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=441","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.drudis.2020.07.011","volume":"25","author":"Rathi E.","year":"2020","unstructured":"Rathi E.; Kumar A.; Kini S.G.; Computational approaches in efflux pump inhibitors: Current status and prospects. Drug Discov Today 2020,25(10),1883-1890","journal-title":"Drug Discov Today"},{"key":"ref=442","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/jac\/dkn088","volume":"61","author":"Kumar A.","year":"2008","unstructured":"Kumar A.; Khan I.A.; Koul S.; Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 2008,61(6),1270-1276","journal-title":"J Antimicrob Chemother"},{"key":"ref=443","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1128\/AAC.48.6.1968-1973.2004","volume":"48","author":"Sudano Roccaro A.","year":"2004","unstructured":"Sudano Roccaro A.; Blanco A.R.; Giuliano F.; Rusciano D.; Enea V.; Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 2004,48(6),1968-1973","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=444","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/jac\/dks232","volume":"67","author":"Kalia N.P.","year":"2012","unstructured":"Kalia N.P.; Mahajan P.; Mehra R.; Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob Chemother 2012,67(10),2401-2408","journal-title":"J Antimicrob Chemother"},{"key":"ref=445","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.bcp.2006.03.024","volume":"71","author":"Han Y.","year":"2006","unstructured":"Han Y.; Tan T.M.C.; Lim L.Y.; Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol 2006,71(12),1727-1734","journal-title":"Biochem Pharmacol"},{"key":"ref=446","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1055\/s-2004-835860","volume":"70","author":"Gibbons S.","year":"2004","unstructured":"Gibbons S.; Moser E.; Kaatz G.W.; Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med 2004,70(12),1240-1242","journal-title":"Planta Med"},{"key":"ref=447","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jep.2011.06.039","volume":"137","author":"Chan B.C.L.","year":"2011","unstructured":"Chan B.C.L.; Ip M.; Lau C.B.S.; Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J Ethnopharmacol 2011,137(1),767-773","journal-title":"J Ethnopharmacol"},{"key":"ref=448","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1348-0421.2005.tb03732.x","volume":"49","author":"Fujita M.","year":"2005","unstructured":"Fujita M.; Shiota S.; Kuroda T.; Remarkable synergies between baicalein and tetracycline, and baicalein and &#x3B2;-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 2005,49(4),391-396","journal-title":"Microbiol Immunol"},{"key":"ref=449","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1128\/AAC.00919-08","volume":"53","author":"Lorenzi V.","year":"2009","unstructured":"Lorenzi V.; Muselli A.; Bernardini A.F.; Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrob Agents Chemother 2009,53(5),2209-2211","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=450","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1021\/jm010911z","volume":"44","author":"Chevalier J.","year":"2001","unstructured":"Chevalier J.; Atifi S.; Eyraud A.; Mahamoud A.; Barbe J.; Pag&#xE8;s J.M.; New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J Med Chem 2001,44(23),4023-4026","journal-title":"J Med Chem"},{"key":"ref=451","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ejmech.2008.01.042","volume":"43","author":"German N.","year":"2008","unstructured":"German N.; Wei P.; Kaatz G.W.; Kerns R.J.; Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem 2008,43(11),2453-2463","journal-title":"Eur J Med Chem"},{"key":"ref=452","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1124\/jpet.102.034728","volume":"302","author":"Bhardwaj R.K.","year":"2002","unstructured":"Bhardwaj R.K.; Glaeser H.; Becquemont L.; Klotz U.; Gupta S.K.; Fromm M.F.; Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002,302(2),645-650","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=453","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/AAC.50.2.810-812.2006","volume":"50","author":"Khan I.A.","year":"2006","unstructured":"Khan I.A.; Mirza Z.M.; Kumar A.; Verma V.; Qazi G.N.; Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 2006,50(2),810-812","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=454","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1099\/jmm.0.033167-0","volume":"60","author":"Mirza Z.M.","year":"2011","unstructured":"Mirza Z.M.; Kumar A.; Kalia N.P.; Zargar A.; Khan I.A.; Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol 2011,60(10),1472-1478","journal-title":"J Med Microbiol"},{"key":"ref=455","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.43.10.2404","volume":"43","author":"Markham P.N.","year":"1999","unstructured":"Markham P.N.; Westhaus E.; Klyachko K.; Johnson M.E.; Neyfakh A.A.; Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother 1999,43(10),2404-2408","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=456","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bmc.2005.09.019","volume":"14","author":"Samosorn S.","year":"2006","unstructured":"Samosorn S.; Bremner J.B.; Ball A.; Lewis K.; Synthesis of functionalised 2-Aryl-5-Nitro-1H-indoles and their activity as bacterial nora efflux pump inhibitors. Bioorganic Med Chem 2006,14(3),857-865","journal-title":"Bioorganic Med Chem"},{"key":"ref=457","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1128\/AAC.43.2.335","volume":"43","author":"Aeschlimann J.R.","year":"1999","unstructured":"Aeschlimann J.R.; Dresser L.D.; Kaatz G.W.; Rybak M.J.; Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1999,43(2),335-340","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=458","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1099-1573(200003)14:2<139::AID-PTR608>3.0.CO;2-8","volume":"14","author":"Gibbons S.","year":"2000","unstructured":"Gibbons S.; Udo E.E.; The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the Tet(K) determinant. Phytother Res 2000,14(2),139-140","journal-title":"Phytother Res"},{"key":"ref=459","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0924-8579(03)00220-6","volume":"22","author":"Kaatz G.","year":"2003","unstructured":"Kaatz G.; Moudgal V.V.; Seo S.M.; Hansen J.B.; Kristiansen J.E.; Phenylpiperidine selective serotonin reuptake inhibitors interfere with multi-drug efflux pump activity in Staphylococcus aureus. Int J Antimicrob Agents 2003,22(3),254-261","journal-title":"Int J Antimicrob Agents"},{"key":"ref=460","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1021\/jm201446h","volume":"55","author":"Sabatini S.","year":"2012","unstructured":"Sabatini S.; Gosetto F.; Serritella S.; Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: A promising new class of Staphylococcus aureus NorA efflux pump inhibitors. J Med Chem 2012,55(7),3568-3572","journal-title":"J Med Chem"},{"key":"ref=461","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dks005","volume":"67","author":"Holler J.G.","year":"2012","unstructured":"Holler J.G.; Christensen S.B.; Slotved H.C.; Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. J Antimicrob Chemother 2012,67(5),1138-1144","journal-title":"J Antimicrob Chemother"},{"key":"ref=462","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1073\/pnas.88.11.4781","volume":"88","author":"Neyfakh A.A.","year":"1991","unstructured":"Neyfakh A.A.; Bidnenko V.E.; Lan Bo Chen; Efflux-mediated multidrug resistance in Bacillus subtilis: Similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 1991,88(11),4781-4785","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=463","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jac\/dkg044","volume":"51","author":"Gibbons S.","year":"2003","unstructured":"Gibbons S.; Oluwatuyi M.; Kaatz G.W.; A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 2003,51(1),13-17","journal-title":"J Antimicrob Chemother"},{"key":"ref=464","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1128\/jb.175.15.4927-4929.1993","volume":"175","author":"Guay G.G.","year":"1993","unstructured":"Guay G.G.; Tuckman M.; McNicholas P.; Rothstein D.M.; The tet(K) gene from Staphylococcus aureus mediates the transport of potassium in Escherichia coli. J Bacteriol 1993,175(15),4927-4929","journal-title":"J Bacteriol"},{"key":"ref=465","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/lam.12424","volume":"61","author":"Chovanov&#xE1; R","year":"2015","unstructured":"Chovanov&#xE1; R; Mezovsk&#xE1; J.; The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three salvia species. Lett Appl Microbiol 2015 2015,61(1),58-62","journal-title":"Lett Appl Microbiol 2015"},{"key":"ref=466","author":"Limaverde P.W.","year":"2017","unstructured":"Limaverde P.W.; Campina F.F.; da Cunha F.A.B.; Crispim F.D.; Figueredo F.G.; Lima L.F.; Datiane de M. Oliveira-Tintino, C.; de Matos, Y.M.L.S.; Morais-Braga, M.F.B.; Menezes, I.R.A.; Balbino, V.Q.; Coutinho, H.D.M.; Siqueira-J&#xFA;nior, J.P.; Almeida, J.R.G.S.; Tintino, S.R. Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and &#x3B1;-Terpinene against Staphylococcus aureus IS-58. Food Chem Toxicol 2017","journal-title":"Food Chem Toxicol"},{"key":"ref=467","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.3390\/molecules25173788","volume":"25","author":"Witek K.","year":"2020","unstructured":"Witek K.; Latacz G.; Kaczor A.; Phenylpiperazine 5,5-dimethylhydantoin derivatives as first synthetic inhibitors of Msr(A) efflux pump in Staphylococcus epidermidis. Molecules 2020,25(17),3788","journal-title":"Molecules"},{"key":"ref=468","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/jac\/dkf224","volume":"50","author":"Kaatz G.W.","year":"2002","unstructured":"Kaatz G.W.; Moudgal V.V.; Seo S.M.; Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 2002,50(6),833-838","journal-title":"J Antimicrob Chemother"},{"key":"ref=469","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/00498250701883753","volume":"38","author":"Moriyama Y.","year":"2008","unstructured":"Moriyama Y.; Hiasa M.; Matsumoto T.; Omote H.; Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. Xenobiotica 2008,38(7-8),1107-1118","journal-title":"Xenobiotica"},{"key":"ref=470","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tips.2006.09.001","volume":"27","author":"Omote H.","year":"2006","unstructured":"Omote H.; Hiasa M.; Matsumoto T.; Otsuka M.; Moriyama Y.; The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci 2006,27(11),587-593","journal-title":"Trends Pharmacol Sci"},{"key":"ref=471","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1128\/JB.182.17.4803-4810.2000","volume":"182","author":"Tsukagoshi N.","year":"2000","unstructured":"Tsukagoshi N.; Aono R.; Entry into and release of solvents by Escherichia coli in an organic-aqueous two-liquid-phase system and substrate specificity of the AcrAB-TolC solvent-extruding pump. J Bacteriol 2000,182(17),4803-4810","journal-title":"J Bacteriol"},{"key":"ref=472","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1128\/jb.179.19.6122-6126.1997","volume":"179","author":"White D.G.","year":"1997","unstructured":"White D.G.; Goldman J.D.; Demple B.; Levy S.B.; Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol 1997,179(19),6122-6126","journal-title":"J Bacteriol"},{"key":"ref=473","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1128\/JB.01318-12","volume":"194","author":"Nasie I.","year":"2012","unstructured":"Nasie I.; Steiner-Mordoch S.; Schuldiner S.; New substrates on the block: Clinically relevant resistances for EmrE and homologues. J Bacteriol 2012,194(24),6766-6770","journal-title":"J Bacteriol"},{"key":"ref=474","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","volume":"47","author":"Dean C.R.","year":"2003","unstructured":"Dean C.R.; Visalli M.A.; Projan S.J.; Sum P.E.; Bradford P.A.; Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 2003,47(3),972-978","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=475","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1128\/AAC.40.10.2288","volume":"40","author":"K&#xF6;hler T.","year":"1996","unstructured":"K&#xF6;hler T.; Kok M.; Michea-Hamzehpour M.; Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996,40(10),2288-2290","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=476","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1574-6968.2001.tb10794.x","volume":"202","author":"Morita Y.","year":"2001","unstructured":"Morita Y.; Komori Y.; Mima T.; Kuroda T.; Mizushima T.; Tsuchiya T.; Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol Lett 2001,202(1),139-143","journal-title":"FEMS Microbiol Lett"},{"key":"ref=477","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","volume":"47","author":"Kaatz G.W.","year":"2003","unstructured":"Kaatz G.W.; Moudgal V.V.; Seo S.M.; Kristiansen J.E.; Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003,47(2),719-726","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=478","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S1517-83822009000200007","volume":"40","author":"Moreira M.A.S.","year":"2009","unstructured":"Moreira M.A.S.; Rodrigues P.P.C.F.; Tomaz R.S.; Moraes C.A.; Multidrug efflux systems in Escherichia coli and Enterobacter cloacae obtained from wholesome broiler carcasses. Braz J Microbiol 2009,40(2),241-247","journal-title":"Braz J Microbiol"},{"key":"ref=479","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijantimicag.2010.06.036","volume":"36","author":"Martins A.","year":"2010","unstructured":"Martins A.; Spengler G.; Martins M.; Physiological characterisation of the efflux pump system of antibiotic-susceptible and multi-drug-resistant Enterobacter aerogenes. Int J Antimicrob Agents 2010,36(4),313-318","journal-title":"Int J Antimicrob Agents"},{"key":"ref=480","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S1286-4579(00)01307-1","volume":"2","author":"Joux F.","year":"2000","unstructured":"Joux F.; Lebaron P.; Use of fluorescent probes to assess physiological functions of bacteriaat single-cell level. Microbes Infect 2000,2(12),1523-1535","journal-title":"Microbes Infect"},{"key":"ref=481","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1021\/bi00635a022","volume":"16","author":"Olmsted J.","year":"1977","unstructured":"Olmsted J.; Kearns D.R.; Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids. Biochemistry 1977,16(16),3647-3654","journal-title":"Biochemistry"},{"key":"ref=482","first-page":"657","volume":"20","author":"Martins M.","year":"2006","unstructured":"Martins M.; Santos B.; Martins A.; An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 2006,20(5),657-4","journal-title":"In Vivo"},{"key":"ref=483","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pone.0000365","volume":"2","author":"Viveiros M.","year":"2007","unstructured":"Viveiros M.; Dupont M.; Rodrigues L.; Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2007,2(4),e365","journal-title":"PLoS One"},{"key":"ref=484","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2174\/138945008785747824","volume":"9","author":"Davin-Regli A.","year":"2008","unstructured":"Davin-Regli A.; Bolla J.M.; James C.; Membrane permeability and regulation of drug &#x201C;influx and efflux&#x201D; in enterobacterial pathogens. Curr Drug Targets 2008,9(9),750-759","journal-title":"Curr Drug Targets"},{"key":"ref=485","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijantimicag.2011.03.014","volume":"38","author":"Amaral L.","year":"2011","unstructured":"Amaral L.; Cerca P.; Spengler G.; Ethidium bromide efflux by salmonella: Modulation by metabolic Energy, PH, Ions and phenothia-zines. Int J Antimicrob Agents 2011,38(2),140-145","journal-title":"Int J Antimicrob Agents"},{"key":"ref=486","author":"Amaral L.","year":"2010","unstructured":"Amaral L.; Fanning S.; Pag&#xE9;s J.M.; Efflux Pumps of gram-negative bacteria: Genetic responses to stress and the modulation of their activity by ph, inhibitors, and phenothiazines. Adv Enzymol Relat Areas Mol Biol 2010","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"ref=487","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/138945008785747734","volume":"9","author":"Viveiros M.","year":"2008","unstructured":"Viveiros M.; Martins M.; Couto I.; New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr Drug Targets 2008,9(9),760-778","journal-title":"Curr Drug Targets"},{"key":"ref=488","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cyto.990170405","volume":"17","author":"Jernaes M.W.","year":"1994","unstructured":"Jernaes M.W.; Steen H.B.; Staining of Escherichia coli for flow cytometry: Influx and efflux of ethidium bromide. Cytometry 1994,17(4),302-309","journal-title":"Cytometry"},{"key":"ref=489","author":"Sabnis R.W.","year":"2010","unstructured":"Sabnis R.W.; Handbook of Biological Dyes and Stains: Synthesisand Industrial Applications. 2010"},{"key":"ref=490","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1754-1611-3-18","volume":"3","author":"Paix&#xE3;o L.","year":"2009","unstructured":"Paix&#xE3;o L.; Rodrigues L.; Couto I.; Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng 2009,3(1),18","journal-title":"J Biol Eng"},{"key":"ref=491","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.12.015","volume":"31","author":"Viveiros M.","year":"2008","unstructured":"Viveiros M.; Martins A.; Paix&#xE3;o L.; Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 2008,31(5),458-462","journal-title":"Int J Antimicrob Agents"},{"key":"ref=492","doi-asserted-by":"publisher","first-page":"e00840","DOI":"10.1128\/mBio.00840-16","volume":"7","author":"Blair J.M.A.","year":"2016","unstructured":"Blair J.M.A.; Piddock L.J.V.; How to Measure export via bacterial multidrug resistance efflux pumps. MBio 2016,7(4),e00840-e16","journal-title":"MBio"},{"key":"ref=493","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0005-2787(66)90305-4","volume":"114","author":"Waring M.J.","year":"1966","unstructured":"Waring M.J.; Structural requirements for the binding of ethidium to nucleic acids. Biochim Biophys Acta 1966,114(2),234-244","journal-title":"Biochim Biophys Acta"},{"key":"ref=494","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0022-2836(67)90353-1","volume":"27","author":"Lepecq J.B.","year":"1967","unstructured":"Lepecq J.B.; Paoletti C.; A fluorescent complex between ethidium bromide and nucleic acids. J Mol Biol 1967,27(1),87-106","journal-title":"J Mol Biol"},{"key":"ref=495","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0022-2836(69)90076-X","volume":"43","author":"Wang J.C.","year":"1969","unstructured":"Wang J.C.; Variation of the average rotation angle of the DNA helix and the superhelical turns of covalently closed cyclic &#x3BB; DNA. J Mol Biol 1969,43(1),25-39","journal-title":"J Mol Biol"},{"key":"ref=496","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/nar\/30.3.656","volume":"30","author":"Olavarrieta L.","year":"2002","unstructured":"Olavarrieta L.; Mart&#xED;nez-Robles M.L.; Sogo J.M.; Supercoiling, knotting and replication fork reversal in partially replicated plasmids. Nucleic Acids Res 2002,30(3),656-666","journal-title":"Nucleic Acids Res"},{"key":"ref=497","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-2836(68)90286-6","volume":"33","author":"Bauer W.","year":"1968","unstructured":"Bauer W.; Vinograd J.; The interaction of closed circular DNA with intercalative dyes. J Mol Biol 1968,33(1),141-171","journal-title":"J Mol Biol"},{"key":"ref=498","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1093\/nar\/6.10.3231","volume":"6","author":"Erard M.","year":"1979","unstructured":"Erard M.; Das G.C.; de Murcia G.; Ethidium bromide binding to core particle: Comparison with native chromatin. Nucleic Acids Res 1979,6(10),3231-3254","journal-title":"Nucleic Acids Res"},{"key":"ref=499","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1099\/00221287-54-3-417","volume":"54","author":"Bouanchaud D.H.","year":"1968","unstructured":"Bouanchaud D.H.; Scavizzi M.R.; Chabbert Y.A.; Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci. J Gen Microbiol 1968,54(3),417-425","journal-title":"J Gen Microbiol"},{"key":"ref=500","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/138945008785747789","volume":"9","author":"Seeger M.","year":"2008","unstructured":"Seeger M.; Diederichs K.; Eicher T.; The AcrB efflux pump: Conformational cycling and peristalsis lead to multidrug resistance. Curr Drug Targets 2008,9(9),729-749","journal-title":"Curr Drug Targets"},{"key":"ref=501","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0014-5793(76)80648-5","volume":"69","author":"Sharples D.","year":"1976","unstructured":"Sharples D.; Brown J.R.; Correlation of the base specificity of DNA intercalating ligands with their physico-chemical properties. FEBS Lett 1976,69(1-2),37-40","journal-title":"FEBS Lett"},{"key":"ref=502","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1874285801307010072","volume":"7","author":"Martins M.","year":"2013","unstructured":"Martins M.; McCusker M.P.; Viveiros M.; A simple method for assessment of mdr bacteria for over-expressed efflux pumps. Open Microbiol J 2013,7(1),72-82","journal-title":"Open Microbiol J"},{"key":"ref=503","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jac\/43.1.61","volume":"43","author":"Piddock L.J.V.","year":"1999","unstructured":"Piddock L.J.V.; Jin Y.F.; Ricci V.; Asuquo A.E.; Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 1999,43(1),61-70","journal-title":"J Antimicrob Chemother"},{"key":"ref=504","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/jac\/28.5.639","volume":"28","author":"Mortimer P.G.S.","year":"1991","unstructured":"Mortimer P.G.S.; Piddock L.J.V.; A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1991,28(5),639-653","journal-title":"J Antimicrob Chemother"},{"key":"ref=505","author":"Reissert A.","year":"1893","unstructured":"Reissert A.; On di-&#x3B3;\u2010amidopropyl) acetic acid (Diamino.1.7.Heptanemethyl Acid.4) and its internal condensation product, the octohydro.1.8.Naphtyridine. Reports of the Dtsch Chem Society 1893","journal-title":"Reports of the Dtsch Chem Society"},{"key":"ref=506","author":"Bobra\u0144ski B","unstructured":"Bobra\u0144ski B; Sucharda E.; On a synthesis of 1.5-naphthyridine. Reports of the German Chem Society (AB Ser 1927)","journal-title":"Reports of the German Chem Society (AB Ser 1927)"},{"key":"ref=507","author":"Koller G.","year":"(AB Ser 1927)","unstructured":"Koller G.; On 1.8-Naphthyridine. Reports by Dtsch Chem Society (AB Ser 1927)","journal-title":"Reports by Dtsch Chem Society"},{"key":"ref=508","author":"Koller G.","year":"(AB Ser 1927)","unstructured":"Koller G.; On 1.8-Naphthyridine and its derivatives (Preliminary communication). Reports of the Dtsch Chem Gesellschaft (AB Ser 1927)","journal-title":"Reports of the Dtsch Chem Gesellschaft"},{"key":"ref=509","author":"Koller G.","year":"(AB Ser1927)","unstructured":"Koller G.; On a Synthesis of derivatives of 1.8-naphthyridine. Reports of the Dtsch Chem Gesellschaft (AB Ser1927)","journal-title":"Reports of the Dtsch Chem Gesellschaft"},{"key":"ref=510","author":"Bachand B.","year":"2002","unstructured":"Bachand B.; Antiviral Methods Using [1, 8] Naphthyridine Derivatives. 2002"},{"key":"ref=511","author":"Domagala J.M.","year":"1994","unstructured":"Domagala J.M.; Mich T.F.; Nichols J.B.; Naphthyridine antibacterial agents. 1994"},{"key":"ref=512","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1070\/RC2004v073n07ABEH000856","volume":"73","author":"Litvinov V.P.","year":"2004","unstructured":"Litvinov V.P.; Chemistry and biological activities of 1,8-naphthyridines. Russ Chem Rev 2004,73(7),637-670","journal-title":"Russ Chem Rev"},{"key":"ref=513","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1070\/RC2000v069n03ABEH000553","volume":"69","author":"Litvinov V.P.","year":"2000","unstructured":"Litvinov V.P.; Roman S.V.; Dyachenko V.D.; Naphthyridines. Structure, physicochemical properties and general methods of synthesis. Russ Chem Rev 2000,69(3),201-220","journal-title":"Russ Chem Rev"},{"key":"ref=514","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1016\/j.bmcl.2007.08.006","volume":"17","author":"Srivastava S.K.","year":"2007","unstructured":"Srivastava S.K.; Jaggi M.; Singh A.T.; Anticancer and anti-inflammatory activities of 1,8-Naphthyridine-3-Carboxamide derivatives. Bioorganic Med Chem Lett 2007,17(23),6660-6664","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=515","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1128\/AAC.39.2.413","volume":"39","author":"Guinea J.","year":"1995","unstructured":"Guinea J.; Gargallo-Viola D.; Robert M.; E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens. Antimicrob Agents Chemother 1995,39(2),413-421","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=516","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1128\/AAC.23.5.742","volume":"23","author":"Nakamura S.","year":"1983","unstructured":"Nakamura S.; Nakata K.; Katae H.; Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice. Antimicrob Agents Chemother 1983,23(5),742-749","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=517","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/jm00369a011","volume":"27","author":"Matsumoto J.","year":"1984","unstructured":"Matsumoto J.; Miyamoto T.; Minamida A.; Nishimura Y.; Egawa H.; Nishimura H.; 1,4-Dihydro-4-oxopyridinecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent. J Med Chem 1984,27(3),292-301","journal-title":"J Med Chem"},{"key":"ref=518","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1128\/AAC.23.5.641","volume":"23","author":"Nakamura S.","year":"1983","unstructured":"Nakamura S.; Minami A.; Katae H.; In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother 1983,23(5),641-648","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=519","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/AAC.46.9.3071-3074.2002","volume":"46","author":"Yun H.J.","year":"2002","unstructured":"Yun H.J.; Min Y.H.; Lim J.A.; In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic. Antimicrob Agents Chemother 2002,46(9),3071-3074","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=520","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1248\/bpb.27.641","volume":"27","author":"Kim E.J.","year":"2004","unstructured":"Kim E.J.; Shin W.H.; General pharmacology of DW-286a, a new fluoronaphthyridone antibiotic: Effects on central nervous, cardiovascular, and respiratory systems. Biol Pharm Bull 2004,27(5),641-646","journal-title":"Biol Pharm Bull"},{"key":"ref=521","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1016\/j.bmcl.2009.06.006","volume":"19","author":"Huang X","year":"2009","unstructured":"Huang X; Chen D; Wu N; Zhang A; Jia Z; Li X; The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents. 2009,19(15),4130-4133"},{"key":"ref=522","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.bmcl.2010.03.044","volume":"20","author":"Huang X.","year":"2010","unstructured":"Huang X.; Zhang A.; Chen D.; Jia Z.; Li X.; 4-Substituted 4-(1H-1,2,3-Triazol-1-Yl)Piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. Bioorganic Med Chem Lett 2010,20(9),2859-2863","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=523","author":"Kondo H.","year":"1990","unstructured":"Kondo H.; Taguchi M.; Inoue Y.; Sakamoto F.; Tsukamoto G.; Synthesis and Antibacterial Activity of Thiazolo-, Oxazolo-, and Imidazolo[3,2-a][l,8]Naphthyridinecarboxylic Acids. J Med Chem 1990","journal-title":"J Med Chem"},{"key":"ref=524","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1248\/bpb.19.1457","volume":"19","author":"Ozaki M.","year":"1996","unstructured":"Ozaki M.; Segawa J.; Kitano M.; Structure-antibacterial activity and cytotoxicity relationships of thiazolo and thiazetoquinolone de-rivatives. Biol Pharm Bull 1996,19(11),1457-1462","journal-title":"Biol Pharm Bull"},{"key":"ref=525","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1248\/cpb.30.3530","volume":"30","author":"Tani J.","year":"1982","unstructured":"Tani J.; Mushika Y.; Yamaguchi T.; Studies on biologically active halogenated compounds. IV. Synthesis and antibacterial activity of fluorinated quinoline derivatives. Chem Pharm Bull 1982,30(10),3530-3543","journal-title":"Chem Pharm Bull"},{"key":"ref=526","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1248\/cpb.28.761","volume":"28","author":"Suzuki N.","year":"1980","unstructured":"Suzuki N.; Synthesis of Antimicrobial Agents. V. Synthesis and antimicrobial activities of some heterocyclic condensed 1,8-naphthyridine derivatives. Chem Pharm Bull 1980,28(3),761-768","journal-title":"Chem Pharm Bull"},{"key":"ref=527","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1248\/cpb.32.4914","volume":"32","author":"Hayakawa I.","year":"1984","unstructured":"Hayakawa I.; Suzuki N.; Suzuki K.; Tanaka Y.; Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo(3,2-b)(1,8)naphthyridine derivatives. Chem Pharm Bull 1984,32(12),4914-4922","journal-title":"Chem Pharm Bull"},{"key":"ref=528","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1248\/cpb.28.235","volume":"28","author":"Suzuki N.","year":"1980","unstructured":"Suzuki N.; Tanaka Y.; Dohmori R.; Synthesis of antimicrobial agents. IV. Synthesis and antimicrobial activities of imidazo[4,5-b][1,8]naphthyridine derivafives. Chem Pharm Bull 1980,28(1),235-244","journal-title":"Chem Pharm Bull"},{"key":"ref=529","first-page":"647","volume":"9","author":"Mills D.A.","year":"2008","unstructured":"Mills D.A.; Fekrazad H.M.; Verschraegen C.F.; SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers. Curr Opin Investig Drugs 2008,9(6),647-657","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=530","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1517\/13543784.2012.699038","volume":"21","author":"Abbas J.A.","year":"2012","unstructured":"Abbas J.A.; Stuart R.K.; Vosaroxin: A novel antineoplastic quinolone. Expert Opin Investig Drugs 2012,21(8),1223-1233","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=531","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1517\/14656566.2013.799138","volume":"14","author":"Freeman C.","year":"2013","unstructured":"Freeman C.; Keane N.; Swords R.; Giles F.; Vosaroxin: A new valuable tool with the potential to replace anthracyclines in the treatment of AML? Expert Opin Pharmacother 2013,14(10),1417-1427","journal-title":"Expert Opin Pharmacother"},{"key":"ref=532","doi-asserted-by":"publisher","first-page":"606","DOI":"10.18632\/oncotarget.195","volume":"1","author":"Hawtin R.E.","year":"2010","unstructured":"Hawtin R.E.; Stockett D.E.; Wong O.K.; Lundin C.; Helleday T.; Fox J.A.; Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks. Oncotarget 2010,1(7),606-619","journal-title":"Oncotarget"},{"key":"ref=533","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00280-008-0850-3","volume":"64","author":"Hoch U.","year":"2009","unstructured":"Hoch U.; Lynch J.; Sato Y.; Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Cancer Chemother Pharmacol 2009,64(1),53-65","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=534","first-page":"285","volume":"7","author":"Argiropoulos G.","year":"1992","unstructured":"Argiropoulos G.; Bates M.R.M.; Cherubim P.; Cytotoxic and DNA binding properties of aminoalkyl derivatives of di- and triazaphenanthrenes. Anticancer Drug Des 1992,7(4),285-296","journal-title":"Anticancer Drug Des"},{"key":"ref=535","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1016\/j.bmcl.2004.04.011","volume":"14","author":"Tsuzuki Y.","year":"2004","unstructured":"Tsuzuki Y.; Tomita K.; Sato Y.; Kashimoto S.; Chiba K.; Synthesis and structure-activity relationships of 3-Substituted 1,4-Dihydro-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridines as novel antitumor agents. Bioorganic Med Chem Lett 2004,14(12),3189-3193","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=536","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1211\/jpp.61.08.0010","volume":"61","author":"Banti I.","year":"2010","unstructured":"Banti I.; Nencetti S.; Orlandini E.; Lapucci A.; Breschi M.C.; Fogli S.; Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells. J Pharm Pharmacol 2010,61(8),1057-1066","journal-title":"J Pharm Pharmacol"},{"key":"ref=537","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3892\/ijo.2012.1659","volume":"41","author":"Hwang H.J.","year":"2012","unstructured":"Hwang H.J.; Kang Y.J.; Hossain M.A.; Novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, MHY-449, induces apoptosis and cell cycle arrest in HCT116 human colon cancer cells. Int J Oncol 2012,41(6),2057-2064","journal-title":"Int J Oncol"},{"key":"ref=538","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4196\/kjpp.2013.17.6.517","volume":"17","author":"Hwang Y.J.","year":"2013","unstructured":"Hwang Y.J.; Chung M.L.; Sohn U.D.; Cytotoxicity and structure-activity relationships of naphthyridine derivatives in human cervical cancer, leukemia, and prostate cancer. Korean J Physiol Pharmacol 2013,17(6),517-523","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref=539","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3184\/174751914X13910886393992","volume":"38","author":"Elansary A.K.","year":"2014","unstructured":"Elansary A.K.; Moneer A.A.; Kadry H.H.; Gedawy E.M.; Synthesis and Antitumour Activity of Certain Pyrido[2,3- d] Pyrimidine and 1,8-naphthyridine Derivatives. J Chem Res 2014,38(3),147-153","journal-title":"J Chem Res"},{"key":"ref=540","author":"Gao L.Z.","year":"2015","unstructured":"Gao L.Z.; Li T.; Yu X.S.; Huang W.L.; Zhao H.; Hu G.Q.; [Design, synthesis, antibacterial and anti-cell proliferation activities of [1,2,4]triazino[3,4-h] [1,8]naphthyridine-8-one-7-carboxylic acid derivatives]. Yao Xue Xue Bao 2015","journal-title":"Yao Xue Xue Bao"},{"key":"ref=541","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.ejmech.2009.03.015","volume":"44","author":"Kumar V.","year":"2009","unstructured":"Kumar V.; Jaggi M.; Singh A.T.; 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity. Eur J Med Chem 2009,44(8),3356-3362","journal-title":"Eur J Med Chem"},{"key":"ref=542","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/co500120b","volume":"17","author":"Fu L.","year":"2015","unstructured":"Fu L.; Feng X.; Wang J.J.; Efficient synthesis and evaluation of antitumor activities of novel functionalized 1,8-naphthyridine derivatives. ACS Comb Sci 2015,17(1),24-31","journal-title":"ACS Comb Sci"},{"key":"ref=543","author":"Oh Y.S.","year":"1998","unstructured":"Oh Y.S.; Cho S.H.; Syntheses of new pyridonecarboxylic acid derivatives containing 1- or 2-naohthyl substituents at N-1 and their anti-HIV-RT activities. J Heterocycl Chem 1998","journal-title":"J Heterocycl Chem"},{"key":"ref=544","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1016\/j.bmcl.2010.08.135","volume":"20","author":"Williams P.D.","year":"2010","unstructured":"Williams P.D.; Staas D.D.; Venkatraman S.; Potent and selective HIV-1 ribonuclease h inhibitors based on a 1-Hydroxy-1,8-Naphthyridin-2(1H)-one scaffold. Bioorganic Med Chem Lett 2010,20(22),6754-6757","journal-title":"Bioorganic Med Chem Lett"},{"key":"ref=545","first-page":"997","volume":"247","author":"Kreutner W.","year":"1988","unstructured":"Kreutner W.; Sherwood J.; Sehring S.; Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation. J Pharmacol Exp Ther 1988,247(3),997-1003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=546","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1021\/jm00119a010","volume":"31","author":"Sherlock M.H.","year":"1988","unstructured":"Sherlock M.H.; Kaminski J.J.; Tom W.C.; Antiallergy agents. 1. Substituted 1,8-naphthyridin-2(1H)-ones as inhibitors of SRS-A re-lease. J Med Chem 1988,31(11),2108-2121","journal-title":"J Med Chem"},{"key":"ref=547","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1248\/cpb.36.4403","volume":"36","author":"Kuo S.C.","year":"1988","unstructured":"Kuo S.C.; Tsai S.Y.; Li H.T.; Wu C.H.; Ishii K.; Nakamura H.; Studies on Heterocyclic Compounds. IX.1) Synthesis and antiallergic activity of Furo[2,3-b][1,8]Naphthyridine-3,4(2H,9H)-Diones and 4H-Furo[2,3-d]Pyrido[1,2-a]-Pyrimidine-3,4(2H)-Diones. Chem Pharm Bull 1988,36(11),4403-4407","journal-title":"Chem Pharm Bull"},{"key":"ref=548","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1021\/jm030306r","volume":"46","author":"Hutchinson J.H.","year":"2003","unstructured":"Hutchinson J.H.; Halczenko W.; Brashear K.M.; Nonpeptide Av&#x3B2;3 antagonists. 8. In vitro and in vivo evaluation of a potent Av&#x3B2;3 antagonist for the prevention and treatment of osteoporosis. J Med Chem 2003,46(22),4790-4798","journal-title":"J Med Chem"},{"key":"ref=549","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejmech.2006.10.015","volume":"42","author":"Raboisson P.","year":"2007","unstructured":"Raboisson P.; DesJarlais R.L.; Reed R.; Identification of novel short chain 4-substituted indoles as potent &#x3B1;v&#x3B2;3 antagonist using structure-based drug design. Eur J Med Chem 2007,42(3),334-343","journal-title":"Eur J Med Chem"},{"key":"ref=550","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1021\/jm049874c","volume":"47","author":"Coleman P.J.","year":"2004","unstructured":"Coleman P.J.; Brashear K.M.; Askew B.C.; Nonpeptide &#x3B1; v &#x3B2; 3 Antagonists. Part 11: Discovery and preclinical evaluation of potent &#x3B1; v &#x3B2; 3 antagonists for the prevention and treatment of osteoporosis. J Med Chem 2004,47(20),4829-4837","journal-title":"J Med Chem"},{"key":"ref=551","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1021\/jm00104a013","volume":"35","author":"Suzuki F.","year":"1992","unstructured":"Suzuki F.; Kuroda T.; Kawakita T.; New Bronchodilators. 3. Imidazo[4,5-c][1,8]Naphthyridin-4(5H)-Ones. J Med Chem 1992,35(26),4866-4874","journal-title":"J Med Chem"},{"key":"ref=552","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1021\/jm00395a015","volume":"30","author":"Santilli A.A.","year":"1987","unstructured":"Santilli A.A.; Scotese A.C.; Bauer R.F.; Bell S.C.; 2-Oxo-1,8-naphthyridine-3-carboxylic acid derivatives with potent gastric antisecretory properties. J Med Chem 1987,30(12),2270-2277","journal-title":"J Med Chem"},{"key":"ref=553","author":"Dedieu-Chaufour C.","year":"1991","unstructured":"Dedieu-Chaufour C.; Hertz F.; Caussade F.; Cloarec A.; Pharmacological profile of up 5145-52, 1 an original antiulcer and antisecretory agent. J Pharmacol Exp Ther 1991","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=554","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1021\/ja01211a064","volume":"68","author":"Adams J.T.","year":"1946","unstructured":"Adams J.T.; Bradsher C.K.; Breslow D.S.; Amore S.T.; Hauser C.R.; Synthesis of antimalarials; synthesis of certain 1,5- and 1,8-naphthyridine derivatives. J Am Chem Soc 1946,68(7),1317-1319","journal-title":"J Am Chem Soc"},{"key":"ref=555","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1071\/CH9841065","volume":"37","author":"Barlin G.","year":"1984","unstructured":"Barlin G.; Tan W.; Potential antimalarials. I. 1,8-naphthyridines. Aust J Chem 1984,37(5),1065","journal-title":"Aust J Chem"},{"key":"ref=556","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/jm020391n","volume":"46","author":"Barreiro E.J.","year":"2003","unstructured":"Barreiro E.J.; Camara C.A.; Verli H.; Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: A new class of potent and selective acetylcholinesterase inhibitors. J Med Chem 2003,46(7),1144-1152","journal-title":"J Med Chem"},{"key":"ref=557","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pbb.2013.05.006","volume":"109","author":"Gautam B.K.","year":"2013","unstructured":"Gautam B.K.; Jindal A.; Dhar A.K.; Mahesh R.; Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system. Pharmacol Biochem Behav 2013,109,91-97","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=558","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/cbdd.12271","volume":"83","author":"Mahesh R.","year":"2014","unstructured":"Mahesh R.; Dhar A.K.; Jindal A.; Bhatt S.; Design, synthesis and evaluation of antidepressant activity of novel 2-methoxy 1, 8 naphthyridine 3-carboxamides as 5-HT3 receptor antagonists. Chem Biol Drug Des 2014,83(5),583-591","journal-title":"Chem Biol Drug Des"},{"key":"ref=559","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/cbdd.12370","volume":"84","author":"Dhar A.K.","year":"2014","unstructured":"Dhar A.K.; Mahesh R.; Jindal A.; Devadoss T.; Bhatt S.; Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression. Chem Biol Drug Des 2014,84(6),721-731","journal-title":"Chem Biol Drug Des"},{"key":"ref=560","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1248\/bpb.25.798","volume":"25","author":"Leonard J.T.","year":"2002","unstructured":"Leonard J.T.; Gangadhar R.; Gnanasam S.K.; Ramachandran S.; Saravanan M.; Sridhar S.K.; Synthesis and pharmacological activities of 1,8-naphthyridine derivatives. Biol Pharm Bull 2002,25(6),798-802","journal-title":"Biol Pharm Bull"},{"key":"ref=561","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0223-5234(99)80099-3","volume":"34","author":"Ferrarini P.L.","year":"1999","unstructured":"Ferrarini P.L.; Mori C.; Calderone V.; Synthesis of 1,8-naphthyridine derivatives: Potential antihypertensive agents - Part VIII. Eur J Med Chem 1999,34(6),505-513","journal-title":"Eur J Med Chem"},{"key":"ref=562","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0223-5234(01)01277-6","volume":"36","author":"Badawneh M.","year":"2001","unstructured":"Badawneh M.; Ferrarini P.L.; Calderone V.; Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X. Eur J Med Chem 2001,36(11-12),925-934","journal-title":"Eur J Med Chem"},{"key":"ref=563","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/jhet.5570340520","volume":"34","author":"Ferrarini P.L.","year":"1997","unstructured":"Ferrarini P.L.; Mori C.; Badawneh M.; Unusual nitration of substituted 7-amino-1,8-naphthyridine in the synthesis of compounds with antiplatelet activity. J Heterocycl Chem 1997,34(5),1501-1510","journal-title":"J Heterocycl Chem"},{"key":"ref=564","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0014-827X(00)00085-9","volume":"55","author":"Ferrarini P.L.","year":"2000","unstructured":"Ferrarini P.L.; Mori C.; Badawneh M.; Synthesis and antiplatelet activity of some 3-phenyl-1,8-naphthyridine derivatives. Farmaco 2000,55(9-10),603-610","journal-title":"Farmaco"},{"key":"ref=565","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0014-827X(01)01075-8","volume":"56","author":"Ferrarini P.L.","year":"2001","unstructured":"Ferrarini P.L.; Badawneh M.; Franconi F.; Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives. Farmaco 2001,56(4),311-318","journal-title":"Farmaco"},{"key":"ref=566","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-46304-4_45","author":"Anand N.","year":"1975","unstructured":"Anand N.; Sulfonamides and Sulfones. Mechanism of Action of Antimicrobial and Antitumor Agents 1975","journal-title":"Mechanism of Action of Antimicrobial and Antitumor Agents"},{"key":"ref=567","author":"Trefouel J.","year":"1935","unstructured":"Trefouel J.; Nitti F.; Bovet D.; Action of P-aminophenylsulfamide in experimental streptococcus infections of mice and rabbits. C R Seances Soc Biol Fil 1935","journal-title":"C R Seances Soc Biol Fil"},{"key":"ref=568","first-page":"291","volume":"120","author":"Fouts J.R.","year":"1957","unstructured":"Fouts J.R.; Kamm J.J.; Brodie B.B.; Enzymatic reduction of prontosil and other azo dyes. J Pharmacol Exp Ther 1957,120(3),291-300","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=569","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4684-1248-2_15","volume":"B","author":"Goulian M","year":"1986","unstructured":"Goulian M; Bleile BM; Dickey LM; Mechanism of thymineless death. Adv Exp Med Biol 1986,B(Pt B),89-95","journal-title":"Adv Exp Med Biol"},{"key":"ref=570","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.1016\/S0021-9258(19)86714-5","volume":"254","author":"Roland S.","year":"1979","unstructured":"Roland S.; Ferone R.; Harvey R.J.; Styles V.L.; Morrison R.W.; The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase. J Biol Chem 1979,254(20),10337-10345","journal-title":"J Biol Chem"},{"key":"ref=571","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/jps.2600570902","volume":"57","author":"Seydel J.K.","year":"1968","unstructured":"Seydel J.K.; Sulfonamides, structure-activity relationship, and mode of action. Structural problems of the antibacterial action of 4-aminobenzoic acid (PABA) antagonists. J Pharm Sci 1968,57(9),1455-1478","journal-title":"J Pharm Sci"},{"key":"ref=572","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3998\/ark.5550190.0010.611","volume":"2009","author":"Argyropoulou I.","year":"2009","unstructured":"Argyropoulou I.; Geronikaki A.; Vicini P.; Zani F.; Synthesis and biological evaluation of sulfonamide thiazole and benzothiazole derivatives as antimicrobial agents. ARKIVOC 2009,2009(6),89-102","journal-title":"ARKIVOC"},{"key":"ref=573","first-page":"74","volume":"21","author":"Woods D.D.","year":"1940","unstructured":"Woods D.D.; The Relation of P-Aminobenzoic acid to the mechanism of the action of sulphanilamide. Br J Exp Pathol 1940,21,74","journal-title":"Br J Exp Pathol"},{"key":"ref=574","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2174\/138161208783877956","volume":"14","author":"Masereel B.","year":"2008","unstructured":"Masereel B.; Thiry A.; Dogne J-M.; Supuran C.; Anticonvulsant sulfonamides\/sulfamates\/sulfamides with carbonic anhydrase inhibitory activity: Drug design and mechanism of action. Curr Pharm Des 2008,14(7),661-671","journal-title":"Curr Pharm Des"},{"key":"ref=575","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867033457647","volume":"10","author":"Scozzafava A.","year":"2005","unstructured":"Scozzafava A.; Owa T.; Mastrolorenzo A.; Supuran C.; Anticancer and antiviral sulfonamides. Curr Med Chem 2005,10(11),925-953","journal-title":"Curr Med Chem"},{"key":"ref=576","first-page":"55","author":"casini A.","year":"2005","unstructured":"casini A.; Scozzafava A.; Mastrolorenzo A.; Supuran C.; Sulfonamides and sulfonylated derivatives as anticancer agents. Curr Cancer Drug Targets 2005(1),55-75","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=577","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/metabo7030048","volume":"7","author":"Supuran C.T.","year":"2017","unstructured":"Supuran C.T.; Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites 2017,7(3),48","journal-title":"Metabolites"},{"key":"ref=578","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archopht.1939.00860040015001","volume":"21","author":"Forster W.G.","year":"1939","unstructured":"Forster W.G.; Treatment of trachoma with sulfanilamide. Arch Ophthalmol 1939,21(4),577-580","journal-title":"Arch Ophthalmol"},{"key":"ref=579","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-9394(39)90817-2","volume":"22","author":"Hirschfelder M.","year":"1939","unstructured":"Hirschfelder M.; Treatment of trachoma with sulfanilamide. Am J Ophthalmol 1939,22(3),299-300","journal-title":"Am J Ophthalmol"},{"key":"ref=580","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/infdis\/81.2.175","volume":"81","author":"Hamre D.","year":"1947","unstructured":"Hamre D.; Rake G.; Studies on Lymphogranuloma venereum; the action of some antibiotic substances and sulfonamides in vitro and in vivo upon the agents of Feline pneumonitis and Lymphogranuloma venereum. J Infect Dis 1947,81(2),175-190","journal-title":"J Infect Dis"},{"key":"ref=581","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1084\/jem.71.1.13","volume":"71","author":"Coggeshall L.T.","year":"1940","unstructured":"Coggeshall L.T.; The Selective action of sulfanilamide on the parasites of experimental malaria in monkeys in vivo and in vitro. J Exp Med 1940,71(1),13-20","journal-title":"J Exp Med"},{"key":"ref=582","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0002-9610(42)90696-2","volume":"56","author":"Goldberger H.A.","year":"1942","unstructured":"Goldberger H.A.; The potentiation of the sulfonamides in the local therapy of wounds and surgical infections by the use of oxidants. Am J Surg 1942,56(2),353-374","journal-title":"Am J Surg"},{"key":"ref=583","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3181\/00379727-51-13809","volume":"51","author":"Sabin A.B.","year":"1942","unstructured":"Sabin A.B.; Warren J.; Therapeutic effectiveness of certain sulfonamides on infection by an intracellular protozoon (toxoplasma). Exp Biol Med 1942,51(1),19-23","journal-title":"Exp Biol Med"},{"key":"ref=584","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/infdis\/66.2.111","volume":"66","author":"Senekji H.A.","year":"1940","unstructured":"Senekji H.A.; The effect of sulfanilamide and trypaflavin on cultures of Leishmania tropica. J Infect Dis 1940,66(2),111-112","journal-title":"J Infect Dis"},{"key":"ref=585","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2307\/3272904","volume":"28","author":"Rodaniche E.C.","year":"1942","unstructured":"Rodaniche E.C.; Kirsner J.B.; The effect of sulfonamide compounds on the growth of Endamoeba histolytica in Culture. J Parasitol 1942,28(6),441","journal-title":"J Parasitol"},{"key":"ref=586","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00045391-200207000-00009","volume":"9","author":"Prandota J.","year":"2002","unstructured":"Prandota J.; Furosemide: Progress in understanding its diuretic, anti-inflammatory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases. Am J Ther 2002,9(4),317-328","journal-title":"Am J Ther"},{"key":"ref=587","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2337\/diab.37.7.847","volume":"37","author":"Boyd A.E.","year":"1988","unstructured":"Boyd A.E.; Sulfonylurea receptors, ion channels, and fruit flies. Diabetes 1988,37(7),847-850","journal-title":"Diabetes"},{"key":"ref=588","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1021\/jm901902w","volume":"53","author":"de los R&#xED;os C.","year":"2010","unstructured":"de los R&#xED;os C.; Egea J.; Marco-Contelles J.; Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. J Med Chem 2010,53(14),5129-5143","journal-title":"J Med Chem"},{"key":"ref=589","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1389557511307010070","volume":"13","author":"Shoaib Ahmad Shah S.","year":"2012","unstructured":"Shoaib Ahmad Shah S.; Rivera G.; Ashfaq M.; Recent Advances in medicinal chemistry of sulfonamides. rational design as antitumoral, anti-bacterial and anti-inflammatory agents. MiniReviews Med Chem 2012,13(1),70-86","journal-title":"MiniReviews Med Chem"},{"key":"ref=590","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.3390\/molecules26237400","volume":"26","author":"Ara&#xFA;jo-Neto J.B.","year":"2021","unstructured":"Ara&#xFA;jo-Neto J.B.; Silva M.M.C.; Oliveira-Tintino C.D.M.; Enhancement of antibiotic activity by 1,8-naphthyridine derivatives against multi-resistant bacterial strains. Molecules 2021,26(23),7400","journal-title":"Molecules"},{"key":"ref=591","first-page":"147","author":"Oliveira-Tintino CD de M","year":"2020","unstructured":"Oliveira-Tintino CD de M; Tintino SR; Muniz DF; Do 1,8-naphthyridine sulfonamides possess an inhibitory action against tet(k) and msra efflux pumps in multiresistant Staphylococcus aureus strains? Microb Pathog 2020,147","journal-title":"Microb Pathog"},{"key":"ref=592","first-page":"160","author":"Oliveira-Tintino C.D de M.","year":"2021","unstructured":"Oliveira-Tintino C.D de M.; Tintino S.R.; Muniz D.F.; Chemical synthesis, molecular docking and mepa efflux pump inhibitory effect by 1,8-naphthyridines sulfonamides. Eur J Pharm Sci 2021,160","journal-title":"Eur J Pharm Sci"},{"key":"ref=593","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jgar.2020.11.027","volume":"24","author":"Oliveira-Tintino C.D.M.","year":"2021","unstructured":"Oliveira-Tintino C.D.M.; Muniz D.F.; Barbosa C.R.S.; The 1,8-naphthyridines sulfonamides are NorA efflux pump inhibitors. J Glob Antimicrob Resist 2021,24,233-240","journal-title":"J Glob Antimicrob Resist"},{"key":"ref=594","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/cmdc.202100282","volume":"16","author":"Cedraro N.","year":"2021","unstructured":"Cedraro N.; Cannalire R.; Astolfi A.; From quinoline to quinazoline-based S. aureus nora efflux pump inhibitors by coupling a focused scaffold hopping approach and a pharmacophore search. Chem Med Chem 2021,16(19),3044-3059","journal-title":"Chem Med Chem"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221212101501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211856\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221212101501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T09:01:30Z","timestamp":1684832490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211856\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":594,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666221212101501","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}